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Abstract
The emergence of the Internet of Things (IoT) and Artificial Intelligence (AI) have elicited
increased interest in many areas of our daily lives. These include health, agriculture, avia-
tion, manufacturing, cities management and many others. In the health sector, portable vital
sign monitoring devices are being developed using the IoT technology to collect patients’ vital
signs in real-time. The vital sign data acquired by wearable devices is quantitative and machine
learning techniques can be applied to find hidden patterns in the dataset and help the medical
practitioner with decision making. There are about 30000 diseases known to man and no hu-
man being can possibly remember all of them, their relations to other diseases, their symptoms
and whether the symptoms exhibited by the patients are early warnings of a fatal disease. In
light of this, Medical Decision Support Systems (MDSS) can provide assistance in making
these crucial assessments. In most decision support systems factors affect each other; they can
be contradictory, competitive, and complementary. All these factors contribute to the overall
decision and have different degrees of influence [85]. However, while there is more need for au-
tomated processes to improve the health-care sector, most of MDSS and the associated devices
are still under clinical trials. This thesis revisits cyber physical health systems (CPHS) with
the objective of designing and implementing a data analytics platform that provides patient
condition monitoring services in terms of patient prioritisation and disease identification [1].
Different machine learning algorithms are investigated by the platform as potential candidate
for achieving patient prioritisation. These include multiple linear regression, multiple logis-
tic regression, classification and regression decision trees, single hidden layer neural networks
and deep neural networks. Graph theory concepts are used to design and implement disease
identification. The data analytics platform analyses data from biomedical sensors and other
descriptive data provided by the patients (this can be recent data or historical data) stored in a
cloud which can be private local health Information organisation (LHIO) or belonging to a re-
gional health information organisation (RHIO). Users of the data analytics platform consisting
of medical practitioners and patients are assumed to interact with the platform through cities’
pharmacies , rural E-Health kiosks end user applications. Keywords: Medical decision sup-
port system, data science, health-care, decision trees, graph theory, artificial intelligence, deep
learning and machine learning.
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Chapter 1
Introduction
1.1 Motivation
The incessant pursuit of technological advancements and improvements has significantly in-
creased over the last few decades. One of the fundamental aims of this quest has been to
improve human health and well-being through medical technology. The continuous infusion
of technology and medicine has led to the conquest of numerous medical barriers as a result
of the development of sophisticated high-tech medical apparatus. Whilst technology has al-
ways played a paramount role in the medical field, the integration and evolution of technology
has been a gradual process. Earlier technological discoveries are the backbone of today’s ad-
vanced medical technology. Various early scientists have made immense contributions to the
field of medical technology, which have spearheaded the improvement of medical apparatus
that improve human health and well-being.
One of medicine’s pivotal inventions is the invention of the microscope by Zacharias and Hans
Jansen. The microscope revolutionized medical engineering. The Jansen’s first rendition of
the microscope was a multi-lensed tube created in 1595, which had a magnification of 3x to 9x
[88]. Thereafter, modifications on this invention began with Galileo Galilei in the early 1600s
who included a focusing component to the microscope. Antonie Philips Van Leeuwenhoek
and Robert Hooke who both created variations of the microscope between 1630 and 1725
improved on the magnification of this device, increasing it to up to 270x [60]. After centuries
of modifications and improvements, microscopes today are used for different purposes, with
dissection microscopes having a magnification of up to 70x, compound microscopes having
a magnification of 1000x and electron microscopes having a magnification of 10 000 000x.
The invention of the microscope was the beginning of the discovery of an endless medical
dimension. Its role in increasing knowledge on germs, diseases and life at a cellular level has
made it an indispensable apparatus in all areas of medicine. The microscope also opened up
doors for the discovery of many other revolutionary medical discoveries such as germ theory,
penicillin and genetics.
Another ground-breaking technological invention in medicine was the thermometer. The first
functional thermometer - which was a rudimentary water thermoscope that allowed for temper-
1
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ature variations to be taken - was invented by Galileo Galilei in the late 1500s [78]. This inven-
tion was later modified by Santorio in 1612 through the addition of a numerical scale which
made it the first oral clinical thermometer. However the inaccuracies of these thermometers
led Ferdinand II to improve on the design of the device by replacing water with alcohol in the
thermometer. The lack of standardization resulted in physicist Daniel Gabriel Fahrenheit mod-
ifying the thermometer by replacing alcohol with mercury and introducing a self-named scale -
the Fahrenheit Scale - which was able to give more precise temperature readings [50]. Another
variation of the same thermometer was introduced by Anders Celsius in 1742 who introduced
his own scale - the Celsius Scale. Thereafter, variations of the thermometer were invented for
recording temperature in different body parts. Apart from Santorios clinical thermometer, Sir
Thomas Allbutt invented the first portable medical thermometer for body temperature in 1867
whilst Theodore Hannes Benzinger invented the first ear thermometer during the Second World
War, which was later modified into an infrared ear thermometer by Dr Jacob Farden in 1984
[8]. The invention of the thermometer greatly improved on knowledge of the human body, the
nature of diseases and the accurate prescription of medicine as body temperature is used as a
necessary measure in many medical diagnoses today.
The invention of the hypodermic needle (which is usually used with a syringe to either extract
or inject fluid) changed the way in which medicines were administered to people and increased
the rate at which these medicines became effective in the body. The earliest hypodermic needle
was invented by Christopher Wren who used it to inject dogs in 1656 [34]. In 1660, Johann
Daniel Major and Johann Sigismund Elsholtz were the first to use the hypodermic needle on a
human being however there were fatal consequences to this which made the needle a contro-
versial medical tool [22]. The first successful hypodermic needle was invented by Dr Francis
Rynd in 1844, and it was later modified by Dr Alexander Wood in 1851 when he created
the all glass syringe [34]. The popularity of the hypodermic needle and syringe began in the
early 1900s and was used particularly for insulin, morphine and penicillin administration. The
invention of the hypodermic needle was one of the most significant innovations in medical
technology. Today, the hypodermic needle has paved the way for more modified versions such
as microneedles which serve the same purpose however decrease the chance of infection and
eliminate pain.
The medical technologies mentioned above show some of the advancements in technology
that have vastly improved the ways in which medical practitioners assess and treat diseases
today. Technology has, and continues to evolve and the use of technology in the medical
field has become indispensable. The countless technological inventions that have emerged
over the centuries have progressively led to the development of areas such as biotechnology
and information technology which are key elements in the medical field today. Information
technology (IT) in particular has been making innovative transformations in the medical field.
With an increase in the use of information technologies such as smart phones and tablets in
everyday life, the medical field has incorporated these gadgets through the use of telehealth/m-
health and electronic medical records.
According to Collen and Ball [23], the rise in the use of computers since the 1950s has led to
the assimilation of information systems into medicine and healthcare. As a result, there is a
vast spectrum of applications of information technology in healthcare today. One area that has
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been significantly transformed by information technology is medical imaging. Images used in
medicine are of extremely high richness of detail and analysis of such images cannot accurately
be done without the use of information technology. Advances in information technology have
enhanced the quality of images which assist with the virtual construction/deconstruction of the
body for clinical analysis, the detection of abnormalities and testing out medical interventions.
Currently, there has been a gradual increase (particularly in developed countries) in the use
of 3D medical imaging systems. These IT innovations have allowed surgeons to assess and
solve medical anomalies prior to operating on patients and this has reduced risky exploratory
medical procedures.
Through IT, healthcare practitioners have been able to bridge the physical distance between
themselves and patients through telehealth. M-Health (also known as telehealth and e-health)
is “the use of digital information and communication technologies, such as computers and
mobile devices, to access health care services remotely and manage your health care” [19].
Such technologies include personal devices such as cellphones and computers, or remote pa-
tient monitoring devices used by doctors. M-health has been particularly useful in remote
patient treatment. It has allowed for medical services to be available to people who may have
transportation challenges or restricted mobility. Additionally, m-health enables people to make
virtual appointments with doctors and have web-based doctor’s appointments. The infusion of
IT into medicine has not only eased access to healthcare, it has also broadened the scope of
information available for research purposes.
The use of technology in the medical field has increased the effectiveness, efficiency and pro-
gression of medical research. Medical research and innovation play a vital role in the health-
care sector. Health informatics give medical researchers the necessary tools to assess and adjust
medical treatments and procedures, and to uncover possible side-effects of drugs. Addition-
ally, technology has aided medical research through innovations which allow for the cellular
analysis of various organisms. This can be attributed to the micro-scaling of medical research
technologies which make it possible to manipulate biological matter. Moreover, with the rapid
digitalization of the world, there has also been a subsequent increase in the amount of data
available to medical researchers. Today there are numerous online medical databases that are
at the disposal of researchers which help with data comparisons.
With information technology expanding the amounts and types of data available to researchers
in the medical field, it has become increasingly important to have a data science strategy which
will effectively channel and organize data. Data collected in the medical field is highly personal
and extensive, and requires effective data aggregation and handling. According to a study an
estimated thirty percent of the world’s stored data is produced in the medical field [3]. Data
science allows for the medical practitioners to have a vast amount of medical knowledge at
their disposal which can greatly improve their efficiency and the quality of their services. Ad-
ditionally, a functional data science strategy handles data quality paving the way for effective
data analysis and storage methods. Without an effective data science strategy, medical institutes
risk deriving inaccurate and jeopardous conclusions. Moreover, this can also lead to the unlaw-
ful access of information by outsiders. A well-designed data science strategy will encourage
precision medicine and facilitate learning health systems.
Effective medical data science management requires a data repository which will keep an in-
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ventory of all data assets in an organized fashion. The creation of a repository also involves
the reconciliation of vast amounts of data. Such a repository will allow for healthcare practi-
tioners to access electronic healthcare data which can help improve their services. Due to the
highly personal information that can be found in a data science repository, security is of high
importance. The protection of patient information through respecting privacy and honoring
anonymity is maintained through data governance frameworks which warrant that these mea-
sures are secured by cyber security. Due to the large volume of data, it is necessary to have a
team of dedicated data scientists who are responsible for the “processing, cleaning, statistics,
visualization, operational research, management, and archiving/curation” of data [9]. Lastly,
a reliable feedback system such as predictive analytics is valuable in such a broad system. The
use of a data science strategy plays a great role in facilitating improved patient care and simpli-
fying data access for medical research purposes. With the increased assimilation of technology
into medicine and healthcare, improvements in data care systems will ensure the safeguarding
of medical data and knowledge. An overview of a generic healthcare system is depicted in the
Figure 1.1 which shows its ecosystem include many entities and stakeholders from the medical
field. These include i) radiotherapy ii) imaging iii) diagnostic laboratories iv) medical emergen-
cies v) medical home care vi) primary health care and specialist forming a multi-disciplinary
team vii) pharmacies and viii) surgeries.
Healthcare evolution
The IoT and artificial intelligence have played a key role in the evolution of modern healthcare.
Healthcare has indeed evolved from the use of invasive methods to evaluate blood samples
to the use of IoT devices that make use of ultraviolet light to get body vital signs such as:
peripheral oxygen saturation, heart rate, pulse, diastolic blood pressure, systolic blood pressure
and many more. An example of such a device is the Samsung Simband. The devices are being
developed and are available for research.
On the other hand, artificial intelligence is being massively deployed in the health sector to
mitigate the fact that humans have limitation when it comes to processing massive sets of
clinical data. While data emerging from genomics, medical imaging, scientific research and
daily care seems too complex for humans to comprehend especially when the aim is to find
patterns in huge datasets, artificial intelligence is currently used to find meaningful patterns
in such data. Artificial intelligence combined with Big Data technologies are also helping
to increase the speed and accuracy required in the medical field when performing surgical
operations, identifying diseases (for example cancer through image processing), and patient
prioritisation from real time data.
1.2 Research Objective
Research plays a fundamental role in healthcare. Through research, medical practitioners are
able to provide people with effective and equitable healthcare. Over the years, technological
advancements have led to the growth of medical databases and electronic medical records and
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Figure 1.1: Healthcare overview.
this has opened up numerous opportunities for researchers in the health sector. The computer-
ization of medical information has made it easier for researchers to access information which
contributes to the understanding and discovery of disease patterns, the effectiveness of treat-
ment and other factors in the medical field. However, there is a great need for researchers to
have access to information such as anonymized patient data and database access in order to
make research more effective. In an address to the American Medical Association, Barack
Obama stated that too many doctors and patients are making decisions without the benefit of
the latest research [96]. Researchers and medical practitioners are in need of increased access
to the most recent, high quality medical data in order for them to make improvements in the
healthcare sector.
This research aims to motivate research institutes to make anonymised medical data available to
research for the advancement of medical science through machine learning algorithms. Which
can only be effectively used to solve problems only if they have been trained using reliable
data. The Machine Learning (ML) algorithms can be used together with IoT devices to provide
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cheap and reliable health-care. The application and importance of medical data availability for
diagnostic purposes will be shown.
1.3 Research Gap
The first triage systems used in the medical field were used in battlefield situations where there
were mass casualties. Today, triage systems are still used to assess mass casualties in hospitals
through the categorization of patients who are in need of immediate, urgent or non-urgent
medical attention. However, current triage systems are based on pseudoscience and hence
cannot manage a wide range of medical presentations. Triage systems that merely sort patients
into simple categories without specificity are inadequate, especially with the technological
innovations taking place in the medical field. Triage systems should be able to manage critical
illness and injury; giving advice based on the patient’s age. Additionally, certainty can be
added to the triage process through the integration of physiological measured parameters. This
will improve the care given to patients and allow for the system to be used more especially for
emergency treatment purposes. The use of pseudo-science based triage systems has inspired
the need for the development of a scientific based triage system which can help address the
shortcomings of some of the triage systems currently in use. The development and use of a
scientific based triage system will assist medical staff in the patient prioritization process with
increased in specificity; and allow for the applicability of this system in emergency hospital use.
This research will be making use of a scientific based triage system in the patient prioritization
process.
As stated in the research objective, access to medical data plays a fundamental role in research.
Ventola [96] estimated that about 30 percent of the world’s electronic data storage was used by
the health sector. This data can be used to improve medical diagnosis through the integration of
machine learning algorithms in healthcare. However, the use of machine learning algorithms
in healthcare has been limited due to barriers to data access. The key issue today of integrating
machine learning into healthcare has been collecting/accessing and using diverse data for the
analysis and treatment of people. In order for machine learning to be effective, a vast amount
of data needs to be available. Machine learning algorithms in healthcare have proven to be
greatly beneficial in a number of ways. Machine learning has been used in the identification/-
diagnosis of various diseases. One notable machine learning innovation in this area has been
carried out by IBM Watson Health which has incorporated cognitive computing and genomic
tumour sequencing in its diagnostic procedures [102]. Machine learning has also been used
in the development of personalized treatments for patients. IBM Watson Oncology has been
making strides in this regard through its integration of machine learning algorithms to improve
diagnosis by using patient medical information and history [61]. Additionally, the use of ma-
chine learning in drug discovery has also become an area of interest in the medical field, with
the MIT Clinical Machine Learning Group making use of and developing more algorithms to
improve the treatment of diseases such as diabetes [36]. Although various big companies have
started making use of machine learning in the medical field, a gap still exists in patient priori-
tization machine algorithms. This research aims to contribute on machine learning integration
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in healthcare by showing the benefits of increased medical data access to improved patient
prioritization and personalized treatment development.
In summary, three main research gaps have been identified in this work. These include:
1. The lack of more scientific based triage systems in the patient prioritisation process in
healthcare.
2. Inadequate integration of machine learning algorithms in patient prioritisation processes.
3. The lack of intelligent tools to support medical practitioners with disease identification.
1.4 Research Questions
The main aim of this research is to address the research gaps described above by assessing the
effective use of machine learning algorithms in patient diagnosis and prioritisation. This will
be achieved through the use of a science-based solutions. In order to achieve this, four research
questions have been considered to be addressed as core subject of this research work. These
include:
1. Are scientific medical decision support systems more accurate than pseudo-science health
systems?
2. What is the best way to implement a scientific medical decision support systems?
3. What is the most effective way to analyse quantitative and qualitative medical data for
decision making?
4. Is it possible to automate medical knowledge in medical decision support systems?
1.5 Thesis contribution and outlines
This thesis revisits cyber physical health systems (CPHS) with the objective of designing and
implementing a data analytics platform that provides patient condition monitoring services
in terms of patient prioritisation and disease identification [1]. Different machine learning
algorithms are investigated by the platform as potential candidate for achieving patient priori-
tisation. These include multiple linear regression, multiple logistic regression, classification
and regression decision trees, single hidden layer neural networks and deep neural networks.
Graph theory concepts are used to design and implement disease identification. The data ana-
lytics platform analyses data from biomedical sensors and other descriptive data provided by
the patients (this can be recent data or historical data) stored in a cloud which can be private
local health Information organisation (LHIO) or belonging to a regional health information
organisation (RHIO). The users of the data analytics platform consisting of medical practition-
ers and patients are assumed to interact with the platform through cities’ pharmacies , rural
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Figure 1.2: A Regional Health Information Organization Infrastructure.
E-Health kiosks end user applications. This data analytics platform is provided as a platform-
as-service in a cloud ecosystem depicted by Figure 1.3 and Figure 1.2. As revealed by Figure
1.2 , a number of local health information organisation (LHIO) infrastructures can be federated
into a cloud platform owned by a regional health information organisation (RHIO) to provide
services to citizen. These include i) patient condition recognition ii) public health monitoring
to detect the outbreaks of epidemics such as Cholera and Ebola iii) public health management
by taking advantage of the massive data sets generated by the platform to get useful insights
concerning the public health iv) remote access to medical expertise and v) many other rich ser-
vices including ”over-the-cloud” access to shared medical resources such as scanners, M-Rays,
etc.
Figure 1.3 shows different entities that may benefit from the services provided by the RHIO
ecosystem. These include
Home Care: Home care patients for patients with reduced mobility and elderly people could
be improved through the cloud services provided.
Emergency: Emergency services will benefit from the cloud in terms of quicker and better
information dissemination leading to faster response to casualties and other medical emergen-
cies.
Surgery: Through cloud services, additional expertise and resources can be provided to a
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Figure 1.3: Ehealth cloud services end users.
medical team operating in a hospital theater.
Multi-disciplinary Team: These are specialists in one or more fields in medical sciences. An
example of such a team is illustrated in Figure 1.4.
Primary Care Physician: They are also known as primary care providers. These are health
care professionals who practice general medicine. They are also the first contact for a person
with a health concern. See examples of areas of focus in Figure 1.5.
The E-health kiosks can also be used by the community to collect patients’ vital signs and
other descriptive symptoms. The patient data is then relayed into a network and stored in a
cloud. The cloud services then perform situation recognition (disease identification and patient
prioritization). The cloud supports information sharing among a number of entities or orga-
nizations to enable institutions, medical professionals, emergency workers, researchers and
public health planners to access an integrated healthcare system for utilization, planning and
advanced research.
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Figure 1.4: Medical multi-disciplinary team.
Figure 1.5: Primary care physicians areas of focus.
Some of the advantages of this system are [51]:
• Cost effective; unnecessary hospital admissions are avoided and thereby saving costs.
• Time saving; when deployed in well funded or private hospitals. The nurses on duty do
not have to go around taking every patient’s readings since each patient can have a low
costly E-health kit or other smart devices which continuously take readings and update
the medical record database hosted in the private cloud.
• Instant processing; the cloud services can be equipped with an intelligent data analysis al-
gorithm capable of performing patient prioritization and situation recognition. Once new
readings are sent to the database the doctors can monitor and access the patients’ deci-
sion enabling visualizations remotely from their smart devices, tables and smart phones
with no real time constraint.
• Reliable decision making; the machine learning algorithms implemented in this study
for example the deep neural network is known to reach an accuracy close to 100 percent
hence human errors can be eliminated. If given more time to train and more data the
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algorithm’s accuracy increases, training is achieved in a just a few seconds or just a few
minutes depending on the size of the data and number of times given to adjust the biases.
Advances in hardware has made it possible to make use of such algorithms. Personal
computers now posses high computational power. Twenty years ago the fastest personal
computer would take months or years to train such an algorithm.
The main purpose of this research can be summarised as providing decision support through
situation recognition using the cyber domain. Figure 1.6 shows patient’s condition recognition
that includes two main components which form the core of this thesis work:
• Patient prioritisation using the triage system
• Disease identification though symptom check
Figure 1.6: Patient’s Condition Recognition.
The remainder of this thesis is as follows:
Chapter 2 defines and give a brief background of decision support systems, artificial intelli-
gence, machine learning techniques, deep learning, graph theory, natural language processing,
and fuzzy cognitive systems. It also discusses the application of AI in healthcare.
Chapter 3 recalls the history evolution, issues, motivation of the use of ”Patient’s Condition
Recognition” and other related areas of technology in healthcare.
Chapter 4 presents the implementation and applications of machine learning techniques: ”Lo-
gistic Regression, Linear Regression, Classification and Regression Decision Tree, Single Hid-
den Layer Neural Network (Shallow Neural Network) and Multiple Layer Neural Networks
(Deep Neural Network)” to calculate the risk score.
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Chapter 5 discusses the use of graph theory and social network analysis techniques in dis-
ease identification (patients symptoms are matched to symptoms in the database or knowledge
repository).
Chapter 6 discusses the architecture and implementation of the proposed situation recognition
system.
Chapter 7 evaluates the proposed patient prioritisation and disease identification algorithms.
Chapter 8 concludes and outlines future work of this study. The limitations and drawbacks
encountered during the study are also discusses.
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2.1 Decision Support Systems
Decision support systems in healthcare – known as clinical decision support systems – are
applications used to analyse data which will assist medical practitioners with timely, clinical
decision making. In the medical field, decision support systems are used to prepare and review
medical diagnosis in order to ensure accuracy of the final result. Data mining is also used to
assess the patients’ medical history and any research that may have been done on similar cases.
An analysis such as this can make predictions which include symptoms and potential cures
and other possible. Decision support systems are mainly used to manage routine tasks such as
warning of potential problems or diagnosis suggestions. The use of a decision support system
in healthcare centres such as hospitals can greatly improve efficiency, reduce patient waiting
time and lower costs to both the hospital and the patient. The use of decision support systems
in healthcare has been increasing in countries such as the USA which have called for the im-
plementation of such systems. The Health Information Technology for Economic and Clinical
Health (HITECH) Act states that healthcare centres should “demonstrate the meaningful use
of health IT. . . [healthcare] providers must implement one clinical decision support rule. . . ”
[49]. This shows the importance of incorporating such systems in today’s healthcare system.
As this study makes use of machine learning techniques and graph theory to solve medical ser-
vice delivery problems. The following sections will give an introduction to machine learning,
artificial intelligence and graph theory.
2.2 Artificial Intelligence (AI)
Contrary to natural intelligence (NI), which is the intelligence exhibited by human-beings and
animals, Artificial Intelligence (AI) (which is also referred to as Machine Intelligence) is intelli-
gence shown by machines. In 1956, Artificial Intelligence (AI) was established as an academic
discipline which experienced a number of optimistic discovery’s and creations. However, the
discipline also went through numerous failures which led to decreased funding - this period
13
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was referred to as the “AI winter.” Thereafter, the invention of new approaches in Artificial
Intelligence (AI) revitalized the discipline. Traditionally, Artificial Intelligence (AI) research
targets areas such as perception, reasoning and object manipulation. One of the long term
goals of the discipline is general intelligence. The AI discipline incorporates information from
a number of fields which include computer science, neuroscience and psychology. The belief
that human intelligence “can be so precisely described that a machine can be made to simulate
it,” was the foundation of the AI field [35]. The twenty-first century has seen a significant rise
in the use of AI, with AI fast becoming the backbone of the technology industry and resolving
a number of issues in computer science.
In the field of Computer Science, research on Artificial Intelligence is known as ‘the study of
intelligent agents.’ An intelligent agent would be any device that is able to identify and react
to the environment it is in, in order to attain a goal. From a colloquial standpoint, AI is im-
plemented when a machine imitates human cognitive functions which include problem solving
[44]. There has been debate regarding the scope of AI. With the capabilities of machines today
broadening at a fast pace, the ‘AI effect’ has resulted in some previously recognized AI tasks
being removed from the definition of AI. Hence Tesler’s Theorem states that “AI is whatever
hasn’t been done yet,” [39]. An example would be optical character recognition which is often
omitted from AI as it has become a regular technology. As of 2016, some of the recognized
AI capabilities include military simulations, analysis of complex data that includes images and
videos, and autonomous cars [76].
Artificial Intelligence has also become an integral part of the healthcare sector, with AI being
used to assist with patient treatments, medication recommendations and patient monitoring.
Bloom Technology states that Microsoft has developed AI to assist with the discovery of cancer
treatments [14]. Generally, research on cancer is extensive with a vast amount of drugs having
been developed to fight the disease. There are well over 800 different medicines and vaccines
all related to cancer treatment. This has made it difficult for doctors to find the right drugs for
patients as there are too many possibilities and combinations available. In light of this problem,
Microsoft has set out to develop “Hanover” - an AI machine which will memorize all relevant
cancer related information and make predictions on the drug combinations best suited to a
patient. AI has also been found to be useful in assisting doctors identify various skin cancers.
In yet another study, AI has been used to monitor multiple high risk patients which has been
done through data acquired from live doctor-patient interactions [79]. One of the most well-
known and advanced AI inventions was created by IBM which created the IBM Watson. This
AI machine has been able - at some level - to surpass human intelligence. Watson was able to
successfully perform a leukaemia diagnosis.
Figure 2.1 is an illustration of AI in a Venn Diagram.
2.3 Machine Learning (ML)
Machine learning is a sub-field or subset of AI and is in fact an approach to achieve Artificial
Intelligence. It refers to any computer program that can ”learn” by itself without having to
be explicitly programmed by a human. The underlying idea and the phrase originated in Alan
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Figure 2.1: Understanding AI in a Venn-diagram.
Turing’s seminal paper ”Computing Machinery and Intelligence”, which featured a section
on his ”Learning Machine” that could fool a human into believing that it’s real [90]. The
machine takes a small or huge volumes of data, learns from it and then makes a prediction
about something that is related to the data.
Example of machine learning algorithms:
• Linear Regression
• Logistic Regression
• Artificial Neural Networks
• Random Forests
• Naı¨ve Bayes Classifier
• K Means Clustering
• Decision Trees
• Support Vector Machine
• Apriori
• Nearest Neighbour
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2.4 Deep Learning
Deep learning is also known as hierarchical learning or deep structured learning. It is a tech-
nique for implementing machine learning and to be more specific a class or subset of methods
based on data representations. It can make use of supervised or unsupervised algorithms. Deep
learning characteristics are as follows:
• use a cascade of multiple layers of nonlinear processing units for feature extraction and
transformation. Each successive layer uses the output from the previous layer as input
• use some form of gradient descent (stochastic, mini batch or batch) for training via back-
propagation
• use supervised learning (e.g. classification) and/or unsupervised learning (e.g. pattern
analysis)
• learn multiple levels of representations that correspond to different levels of abstraction;
the levels form a hierarchy of concepts.
Figure 2.2 is an illustration of deep learning in a Venn Diagram. The strong relationship among
the three: deep learning, machine learning and artificial intelligence is also shown. There are
all related to big data and other enabling technology for example pattern recognition and neuro
computing as shown in Figure 2.1.
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Figure 2.2: Understanding Deep Learning in a Venn-diagram.
2.4.1 Deep Neural Network
Deep neural network is known to be the development of machine learning theory. Deep neural
learning was introduced as a way to counter the limitations of the perceptron learning algorithm
which could not fully understand the ambiguity of ‘or’ within natural language. In light of this,
Marvin Minsky - a well renowned Artificial Intelligence expert - emphasised the need for
advancements in learning algorithms. Numerous deep learning methods make use of neural
networking structures hence deep learning is often known as deep neural networks.
A deep neural network can be described as a complex neural network with over two layers.
Scholars such as Rifkin (2014) and Danzer (2007) have stated that neural networks normally
have “an input layer, an output layer and at least one hidden layer in between.” Therefore deep
neural networks can be described as ‘feed-forward’ networks. These networks utilize intricate
mathematical modelling for data processing. Generally, neural networks are algorithms which
are used to mimic human brain activity; particularly pattern recognition through the multiple
layers of replicated neural connection. These layers use the ‘feature hierarchy’ process which
entails using machine perception for the categorisation and ordering raw data. The main use of
neural networks is management of unstructured data. Neural networks identify numeric data
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in vector. The phrase “deep learning” describes the level at which information is sorted, going
beyond mere input-output practices. This is a form of machine learning which utilizes Artificial
Intelligence. Hence deep neural networks are part of bigger machine learning applications
which make use of algorithms for fortified learning, regression and cataloguing.
2.5 Decision Trees
Decision trees are basic machine learning models which are used to analyse regression data.
Decision trees create regression models which are structured like a tree. It categorizes a dataset
into multiple, small subsets whilst also accumulatively developing a decision tree. This tree has
decision nodes and leaf nodes. A decision node has at least two branches which each represents
a value for the test in question. A leaf node represents a decision on the numerical target. The
root node is the ultimate decision node as it correlates with the best predictor. Decision trees are
able to operate with both categorical and numerical data. The regression decision tree is used
when the target variable is continuous in nature, including for predictive purposes. Decision
tree learning makes use of decision trees for predictive purposes. This approach is mainly used
in fields such as machine learning and statistics.
Decision trees make use of algorithms and one of these is the Classification and Regression
Decision Tree (CART) algorithm which was introduced by Leo Breiman [63]. CART can be
used to evaluate and resolve classification or regression predictive modelling problems. This
algorithm provides an important base for other essential algorithms such as random forest and
bagged decision trees. According to [74], CART tree is a binary decision tree that is constructed
by splitting a node into two child nodes repeatedly, beginning with the root node that contains
the whole learning sample. CART is amongst the most popular decision tree algorithms used
today.
2.6 Classification and Regression Decision Tree (CART)
A decision tree is an ML algorithm that uses a set of instances in-order to make decisions. The
decision node and the leaf node are the only two types of nodes. Every leaf node is a terminal
node of the tree and specifies the ultimate decision of the tree. The decision nodes are used for
testing a particular attribute.
The unlabeled instance is classified by routing the test case down the tree according to the val-
ues of the attributes tested in successive decision nodes until a leaf is reached. The unlabeled
instance is then classified according to the probability distribution over all classification pos-
sibilities. The ’divide and conquer’ approach is used to construct the decision tree. Initially
an attribute is selected and placed at the root node of the tree. The root node then splits up
and divides the dataset into different subsets, one for every value of the attribute. The value is
specified by the edge between the parent node and its child node. The process is recursively
repeated for every branch of the tree [31].
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2.7 Logistic Regression
The logistic regression model used in fields such as statistics, machine learning and medical
fields is a regression model which makes use of a categorical dependent variable. This model
was developed by 1950s statistician David Cox. In instances where the dependent variable
elicits multiple results, analysis is carried out using multivariate logistic regression. Logistic
regression is also suitable for analysing dichotomous dependent variables. Moreover, it is a
predictive analytic tool. The logistic regression model is used for descriptive and explanatory
purposes particularly where there is a relationship between a dependent binary variable and nu-
merous independent variables. According to [28], logistic regression generates the coefficients
of a formula to predict a logit transformation of the probability of presence of the characteristic
of interest.
Within the medical field, logistic regression has been used in machine learning to assist with
predictive diagnosis in cases where there is trauma or severe injury for example. This approach
was originated from Boyd, Tolson and Copes 1987 Trauma and Injury Severity Score (TRISS)
evaluation method which used logistic regression. Logistic regression has been used to predict
whether or not a person has a particular disease based on various attributes such as age and
body mass index. For the purposes of this research, multivariate logistic regression will be
used in a similar manner. Variables such as systolic blood pressure, diastolic blood pressure,
heart rate and peripheral oxygen saturation will be used to predict a person’s risk score. The
risk score will reflect an individual’s degree of risk in light of various risk factors.
2.8 Graph Theory
The medical research field has a lot of literature and graph based algorithms have been used
for information retrieval and natural language processing. There are high chances of disease
and symptom relationships being mixed up and as a result patients being misdiagnosed and
given the wrong medication. For example the symptoms: Fatigue, Fever, Headache and Sore
throat are related to about 172 medical conditions. To mention but a few: viral pharyngitis,
acute sinusitis, mononucleosis, mumps, medication reaction or side-effect, aseptic meningitis,
thalassemia, multiple sclerosis, sunburn, lyme disease and Diabetes type 2 [48].
One of the most universal models of both natural and human-made structures in computer
science are graphs. Graphs have been used to model various relations and process dynamics
in this field such as biological systems. Graph theory is a division of mathematics which has
been used in computer science. Graph theory “is the study of graphs which are mathematical
structures used to model pair wise relations between objects,”. Graphs have been used to
develop problem solving systems and have been applied in various areas of computer science
such as database networking and data mining. The use of graph theory in computer science
has led to the development algorithms which have been used in various applications. This
theory was developed in 1913 after having built up on and improved the Eulerian graph concept
created by Leonhard Euler in 1735.
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2.8.1 Graph Theory Algorithms
In computer science, graph theory has mainly been used to develop graph algorithms. A num-
ber of algorithms have been used to resolve problems displayed in graph form. Such algorithms
are applied to the resolution of graph theoretical concepts which are then used to resolve the
parallel computer science application problems. Examples of such algorithms include:
• Finding a minimum spanning tree.
• Algorithms to find cycles in a graph.
• Finding graph planarity.
2.8.2 Graph Applications
Graph are used to solve social, physical, information and biological systems.
• Semantic networks - in computational linguistics and natural language processing.
• Travel eCommerce Websites - determining the cheapest route.
• Global Positioning System (GPS) - finding the fastest route or shortest path.
• Social networking - e.g. network of family and friends on social media applications such
as Facebook.
2.8.3 Graph theory and Machine Learning
The recursive neural network model is able to process directed acyclic graphs with labelled
edges. There a a number of fields that make use of graphs in machine learning examples are
computer vision and image processing.
Other graph applications in the medical sciences are as follows[98]:
• Genomics Profiles
• Molecular networks
• Cancer Sub-networks and Pathways
• Drug and Disease Phenotype Network
• Network-based Drug Re-positioning
• Biomedical and Molecular Networks
• TCGA Studies
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2.8.4 Natural Language Processing (NLP)
Natural Language Processing (NLP) is a field of machine learning that studies how computers
process and analyze natural language data. The two categories are rule based and statistical.
2.9 Fuzzy Cognitive Systems and Machine Learning
The fuzzy cognitive maps (FCMs) described in this study are used for disease identification and
pre-diagnosis qualitative predictions. Machine learning algorithms such as Multivariate Linear
Regression (MLR), Neural Networks and Support Vector Machines (SVM) are used to per-
form regressions, predict and score patients. The results from both the FCMs and quantitative
machine learning algorithms are then used to give a much more reliable patient prioritization
list. Algorithms that perform quantitative computations such as the MLR are less reliable on
their own. Hence the use of an hybrid system which makes use of qualitative FCMs to extract
relevant information and provide some quantitative and qualitative output. The output from
FCMs together with quantitative inputs such as body vital signs can be feed into a machine
learning algorithm and compute one score which can be used to prioritize patients. Other more
descriptive results are also given as output and can be used by medical practitioners to make
decisions.
Table 2.1: Machine learning algorithms characteristics and features.
Learning Al-
gorithm Type Function Output
DNN
supervised,
semi-supervised
or unsupervised
linear and non
linear
real values
SNN
supervised
learning
linear and non
linear
real values
MLR supervised linear real values
MLoR supervised linear real values
CART supervised non linear real values
2.10 AI in Healthcare
DermaCompare is one of the revolutionary AI inventions that have transformed medical diag-
nosis in the healthcare industry. DermaCompare is a skin cancer detection application which
runs on “cloud-based artificial intelligence technology,” [83]. Early detection of skin cancer is
crucial for patient treatment, and increases the chances of survival. Dermatologists have been
using Total Body Photography (TBP) – an innovation created 15 years ago – to detect skin
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cancer. However, using TBP has proved to be time-consuming and inaccurate at times as it
is a manual diagnostic procedure. Additionally it is expensive and this has made it inaccessi-
ble to many people. DermaCompare was created to overcome these challenges by providing
a cost-effective, accurate and speedy way of detecting skin cancer. The application mainly
uses image processing software (which is inclusive of knowledge from both military image
software), big data analytics and patented comparing algorithms to aid the analysis of med-
ical images. DermaCompare works closely with dermatology for the early detection of skin
cancer. The DermaCompare application works by using AI algorithms to compare over 50
million known moles on their database to a picture taken by a person on their smartphone. A
summary of relevant information is then generated by the app and a doctor is notified. This
enables doctors to identify melanoma in a speedier and more accurate manner and has vastly
improves telemedicine of skin cancer diagnostics. Babylon – like DermaCompare – is another
AI application used in the healthcare industry that has vastly improved the diagnosis process.
“Babylon is a subscription health service provider that enables users to have virtual consulta-
tions with doctors and health care professionals via text and video messaging through its mobile
application,” (www.babylonhealth.com). Babylon has combined the latest AI technology with
the experience, knowledge and expertise of healthcare practitioners to make access to medical
advice and diagnosis simpler, faster, affordable and accessible. Babylon works through an AI-
powered chatbot triage service which gives patients access to consultations, health monitoring,
tests and kits and AI. The consultation feature gives patients’ access to a GP who can answer
questions on common medical topics. Prescriptions are emailed to the patient. There is also ac-
cess to therapists to discuss topics such as depression. The health monitor feature allows users
to sync their activity tracking devices (e.g. smart watches) to the Babylon app. The delivery
service – test and kits – provides users with the option to request diagnostic kits which can test
for sugar levels, cholesterol, etc. The AI feature pre-screens a user’s symptoms or health con-
dition, increasing the accuracy of triaging patients. Data-driven techniques such as machine
learning have been known to reinforce AI and subsequently improve healthcare services and
systems. One company harnessing the power of machine learning and AI in the healthcare
sector is Google DeepMind. Google DeepMind is a division of Google’s AI company has been
applying machine learning to medical data for diagnostic purposes on its healthcare platform.
It has been applied to the diagnosis of eyes, cancer screening and electronic patient manage-
ment. Google DeepMind is an app which aims to assist (and not replace) medical practitioners;
allowing them to work more efficiently at the touch of a button. The early detection of various
ailments which warrant rapid response will increase patient treatment. Google DeepMind has
collaborated with various hospitals and organizations where it has rendered its services. The
tools mentioned above are just some of the innovations in healthcare AI that have made sig-
nificant impacts. The table below gives a more extensive list of AI tools currently available in
healthcare:
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Table 2.2: Machine Learning Algorithms.
AI Tool Company User Use Specialisation Algorithm
Google
DeepMind
Health
Alphabet
Inc.
(Google
conglomer-
ate)
Practitioner Data min-
ing
Electronic
patient
record
manage-
ment
Kidney
data
Eye dis-
eases
Machine
learning
Verily Alphabet
Inc.
(Google
conglomer-
ate)
Practitioner Data min-
ing Disease
monitoring
Genetic
data
PageRank
WatsonPaths IMB Wat-
son
Practitioner Electronic
medical
records
manage-
ment
Decision
making
Bowyer-
Watson
CareSkore CareSkore Practitioner
Patient
Predictive
analysis
Patient
commu-
nication
service
platform
Person-
alized
population
manage-
ment
Patient
read-
mission
predic-
tion Value
based care
Zeus
Butterfly
Network
Butterfly
Network,
Inc.
Practitioner Medical
imaging
MRI and
ultrasound
Deep learn-
ing
Zephyr
Health
Zephyr
Health
Research Data min-
ing
Data visu-
alization
Machine
learning
CloudMedX CloudMedX
Health
Practitioner Data
mining
Generate
real-time
clinical
insights
Natural
language
processing
Evidence-
based
Machine
learning
Dragon
Medical
Virtual
Assistant
Nuance Patient Enhancing
clinician-
patient
interactions
Communica-
tion
Arbitration
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The application of AI tools in healthcare has been briefly introduced. The next chapter provides
more history about the evolution of healthcare and then discuss some few related studies in
more details.
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Over the last decade, wearable devices have been receiving an increased attention in both the
academic and industrial sectors. Constantly evolving medical devices have resulted in the de-
velopment of portable wearable devices which have been used to empower both health care
professionals and their patients. Portable wearable devices in the medical field are used by
individuals in order to support their general health or recovery through monitor aspects of
their health over a period of time. These devices are defined as “devices that can be worn or
mated with human skin to continuously and closely monitor an individual’s activities, with-
out interrupting or limiting the user’s motions [10].” Portable wearable devices are unique
health support tools as they can be worn as an accessory or implanted into clothes. The use
of non-intrusive physiological detectors, wireless data dispatch systems and medical data pro-
cessing algorithms in these devices allows them to constantly monitor and record patient health
progress. Additionally, both patients and doctors can access real-time feedback and the alerting
system can warn users of any potential health risks. The simple design makes it suitable for
unskilled persons to understand and use. The emergence of portable wearable medical devices
has vastly improved the delivery of point-of-care health services and distance medical manage-
ment, monitoring and support. This has been particularly helpful for chronically ill individuals,
the elderly and people with disabilities. In order to understand the progress that has been made
in the field of wearable technology, it is important to look at the history of these devices.
The market and demand for wearable biomedical sensor devices has been catapulted by the
fitness and health industries. According to Tillmann [89] demand has grown by 25 percent
from 2014 to 2015 and it has been predicted that this rapid growth rate will continue over the
coming 5 years. Synchronously, wearable biomedical sensor devices have started being utilized
more to keep track of stress and human performance during strenuous activities, as well as to
enhance home-based care specifically made for patients with noted health problems. At the
moment, wearable biomedical sensors have been developed to provide ongoing supervision of
human vital signs in a comfortable and noninvasive manner. The consistent monitoring of an
individual’s vital signs enables the establishment of a health baseline which enables both users
and health care practitioners to be signaled when there are any abnormal variations that may
require medical attention.
The shift towards more flexible monitoring devices that amalgamate well with an individual’s
25
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skin and body can aid the increased acceptance of these devices as well as refine monitoring
mechanisms. The authors in [103] states that significant efforts are being made to incorporate
advanced fabrication methods and materials, and apply them to sensors and electronics with the
aim of establishing pliable and conformal electronic devices. The large and inflexible nature of
traditional silicon-based devices can obstruct their “applications in epidermal and implantable
medical sensing” [43]. Materials such as elastomeric substrates and plastic which have been
used as alternates in flexible devices are viewed as being conformal by nature and weightless,
hence providing a more desirable interface with an individual’s’ skin and soft tissue.There
are other studies in conductive and stretchable material used in sensors [65, 87]. In the same
light, Kim et al look into alternative approaches which explore the transmission of thin, minute
traditional devices onto flexible substrates. It has been found that silicon-based electronics
offer unprecedented performance in the processing of data and in terms of general functionality.
Hence the most desirable design for a wearable medical device which is both comfortable and
flexible would require a fusion of progressive, tractile materials and silicon integrated circuits.
A compound approach such as this one takes into account the multiplicity of body silhouettes
and sizes that exist in the populace, easing the production of customized medical devices [42].
Flexibility, adjustability and adaptability boost the quality of signals recorded, and also reduce
inaccuracies [82].
3.1 History
Portable wearable technologies come in various forms which include clothing and accessories
such as watches and glasses. All these technologies make use of progressive computer and
electronic systems. Most designs make use of simple, user-friendly features however each has
its own aesthetic agenda. Currently, there has been a surge in portable wearable devices on
the market. The history of portable wearable devices dates back to the early 1600s, when the
first abacus necklace was invented [40]. Additionally, in China during the Qing Dynasty (1644-
1911) the first abacus ring was invented to make calculations easier for traders. The 1800’s saw
the introduction of the wristwatch which was first worn by the Queen of Naples [13]. Comput-
erized timing devices were created by mathematicians Edward Thorp and Claude Shannon in
1961 as cheating devices during gambling games [17]. The device was improved on by various
people in the 1970s making it more sophisticated. In 1977, C.C Collins introduced a camera-
to-textile wearable system for the blind. The popularity of wearable computers increased in the
1980s [75]. A study states that in 1975, Pulsar released the first calculator watch which became
a trend setter during that time [80]. The watch had a small numeric keypad and came with a
stylus for users. However these elaborate watches - which were made of solid gold - became
popularized when companies such as Casio and Seiko created their own less expensive version
of these watches with some more complex calculators in the early 1980’s. The need for mo-
bility in the media field led Steve Mann to create “a backpack-mounted multimedia computer
in 1981” [40]. In 1994, Mann went on to create a wearable, wireless webcam. Also in 1994,
Edgar Matias and Mike Riucci invented the first wrist computer. The 21st century saw a signif-
icant rise in portable wearable technology advancements and developments. The introduction
of augmented-reality support wearable devices started in 2002 with Kevin Warwick’s Project
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Cyborg which electronically linked his nervous system to an electrode embedded in his wife’s
necklace [99]. The late 2000s saw the beginning of the production of wrist-phones. In 2011,
Google presented the first model of smart glasses in the Google Glass Project. Thereafter, a
number of big companies such as Samsung and Apple introduced their own portable wearable
technology. Today wearable portable technology comes in various forms from rings and head-
bands to glasses and watches. These devices have been used for a multitude of purposes which
include fitness tracking and health monitoring. Portable wearable devices for medical purposes
have become increasingly popular, particularly the ones in the form of a wrist watch.
3.2 Patient’s Condition Recognition
Healthcare is a complex industry generating massive volumes of data emerging from medical
imaging, genomics, sensors, daily care and scientific research which may have hidden patterns
which are difficult to analyse by human beings, both medical and non-medical professionals.
Artificial intelligence is able to provide more insights into this data as it has the potential to
process a huge number of combinations that the human brain cannot mathematically handle,
thus enabling medical professionals to handle the treatment and medical care more effectively
and with more time for empathy. Artificial intelligence has been used in medicine for many
different specialized applications. For example, a reliable epileptic seizure detection model us-
ing an improved wavelet neural network was proposed in [56] while an acute ischaemic stroke
prediction model from physiological time series patterns was proposed in [81] and believed
to be useful in optimizing stroke recovery by manipulating physiological variables. Artificial
intelligence prediction was also proposed in [104] to improve elective surgery scheduling.
3.3 Patient Prioritization
Patient prioritization is an instrumental process in the treatment of patients. It has become in-
creasingly important for hospitals to integrate a patient prioritization system into their everyday
system as it has proven to be greatly beneficial in many aspects which include time manage-
ment, rate of service delivery and diagnosis accuracy. Public hospitals have struggled with
funding and this has impaired the quality of health care provided. Issues which include a lack
of adequate resources; insufficient and outdated medical equipment, limited health care profes-
sionals have all contributed to service provision problems. A study conducted in 2004 showed
that approximately there are are at least 6.7 doctors per 10 000 people [12]. As increasing the
number of medical practitioners available would not be feasible due to financial constraints, the
most effective solution would be to create more efficient hospital systems through the incor-
poration of patient prioritization systems. This research aims to reduce mortality through the
use of patient prioritization. This will ensure patients with time-sensitive illnesses, diseases or
injuries are catered to on time thus reducing the rate of unnecessary deaths. This research will
achieve this by identifying the most suitable patient prioritization and disease identification
algorithm.
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Figure 3.1: Physiological data exhibiting characteristics.
The availability of medical data helps with the investigation of important parameters that
greatly affect the value to be predicted. In a previous study [62], data patterns were identi-
fied as shown in Figure 3.1. These patterns are a key player in discovering new algorithms and
ground breaking implementations and inventions. The Multivariate Linear Regression (MLiR)
algorithm played a huge role in identifying these patterns. A comparison to other algorithms
such as the Support Vector Machine (SVM) and Kmeans Clustering and Gausian Estimator
(KCG) was made. MLiR was found to be the best algorithm. The algorithm was successfully
implemented to solve multiple classification for patient prioritization.
In this study other algorithms such as Multivariate Logistic Regression (MLoR) and Classifi-
cation and Regression Decision Tree (CART) are implemented and the performance of each
is compared to the Multivariate Linear Regression (MLiR). The other algorithms for disease
identifications are also introduced. A web application, a cloud service applications and visual-
izations are designed and implemented.
The Multivariate Logistic Regression (MLoR), Classification and Regression Decision Tree
(CART), Single Hidden Layer Neural Network (SNN), and a Deep Neural Network (DNN),
were implemented and compared to the Multivariate Linear Regression (MLiR), from the pre-
vious study. The DNN is famous for its ability to handle very difficult prediction problems.
Patient Prioritization makes use of qualitative and quantitative variables. An example is the
South African Triage system makes use of qualitative parameters such as Mobility, Trauma,
and (Alert, Reacts to Voice, Reacts to Pain, Unresponsive also known as AVPU). The numeric
parameters are Respiratory Rate, Temperature, Systolic Blood Pressure (SBP) and Heart rate.
The advancement of IoT has seen a lot of vital sign monitoring devices penetrating clinical
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trials and research. An example is the Samsung Simband wearable device which measures pa-
rameters such as Electrocardiogram (ECG), Blood Flow, Blood Pressure, Heart Rate, C02 and
Oxygen Level and Skin Temperature (see Figure 3.2). Most of these can be useful and can be
used together with the South African Triage parameters. The DNN can take many parameters
and still achieve great performance.
3.4 Vital signs monitoring using biomedical wearable sen-
sors
Continuous vital sign monitoring plays an important role in and contributes immensely to the
treatment and prevention of various health issues. Generally, when there is a need to assess a
patient’s vital signs it usually takes place either at a hospital or at the patient’s residence with
the use of considerably large, expensive medical equipment which requires health care person-
nel to be available to operate it. However, contemporary society has developed and introduced
wearable biomedical sensors as a way to reduce costs, increase patient mobility and possibly
improve the quality of data health care practitioners use in patient diagnoses. This notion is
concurred by Hao and Foster [38] who state that the wireless nature of these devices enables
better mobility for patients and improves efficiency levels. In addition to this, the study looks
into the use of wireless body sensor network (WBSNs) in health related applications and found
that the chief driving forces behind the shift towards the use of WBSNs and vital sign monitor-
ing were the increased obesity levels and the aging of the populace. This has led to the need for
significant medical interventions with incidentally significant cost. Similar research focused on
diabetes and cardiovascular disease and concluded that constant monitoring of blood glucose
levels is essential to prevent any further complications related to these illnesses [67]. There
are a various vital signs that are monitored by of wearable vital sign monitoring devices which
include blood pressure, elecotrocardiograph (ECG) patterns and blood glucose. These will
be discussed in greater detail below with specific reference to various studies that have been
conducted regarding the effectiveness of wearable vital sign monitoring devices.
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Figure 3.2: Vital Sign Monitoring using the Samsung Simband.
3.5 Continuous assessment of heart rate and cardiac activity
Traditionally, an individual’s cardiac activity is assessed and monitored in a clinical setting
through the recording of electrocardiograph (ECG) signals. Holter monitors have typically
been used for these purposes, especially after a patient has undergone heart surgery [105].
Even though Holter monitors can effectively monitor cardiac activity, the machine itself is
bulky and has numerous wires which connect to the central unit of the monitor. Hence the use
of such large equipment impedes a patient’s ability to go about their daily activities, is time
consuming and is not ideal for constant cardiac activity monitoring.
Technological breakthroughs in the wearable biomedical sensor domain have resulted in the
evolution and miniaturization of Holter monitors making them more flexible, effective and
portable. Such devices have commonly come in the form of watches which provide real time
information regarding an individual’s cardiac activity as well as allow a person to store and
analyze the recorded information at a later stage on a computer [73]. In recent years, ad-
vancements in technology have allowed for such information to be linked directly to a person’s
cellphone using bluetooth which has increased the accessibility of information. HealthGear is
one such device which allows for the monitoring of heart rate through a person’s pulse. Data
collected using this device is accessible on a cellphone where it can be stored and analyzed in
real time [70]. Other innovations regarding cardiac activity monitoring include more invasive
but comfortable devices. Park et al [45] developed a successful wearable piezoelectric sen-
sor which is inserted in the ear canal and is able to detect heart rate through monitoring the
pressure variances and waveforms of the ear canal area. The success of this innovation was
attributed to the use of an embedded algorithm and the hardware circuit model which allowed
for the refining and detection of ear pulse waves. The last decade has seen the transforma-
tion of the devices used for the monitoring of heart rate and cardiac activity. A study looks
into the development of a t-shirt that measures EKG signals using textile based computing or
‘e-broidery’ [86]. Biomedical sensors in the form of minute EKG electrodes which were em-
broidered with conductive yarn were incorporated into the material of a stretch t-shirt. The
results of this innovation were positive and showed room for further improvement through the
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incorporation of more biomedical sensors in the fabric of the t-shirt. Similarly, another study
also look into the use of biomedical sensors in garments through using the WEALTHY sys-
tem as a means to attain ECG signals. The WEALTHY system is a patented interface used in
some wearable biomedical sensor devices. The incorporation of the WEALTHY system into a
knitted garment enabled users to concurrently record vital signs and parameters extrapolation
and inter-signal elaboration’ that aid in the generation of alert messages and the production of
synoptic patient tables. This system was geared towards monitoring cardiac patients during
their rehabilitation [66].
3.6 Continuous assessment of blood glucose levels
A majority of the devices used to measure, monitor and assess an individual’s blood glucose
levels make use of invasive techniques which usually require the drawing of a small blood
sample. This blood sample is then used together with a digital monitor to determine the blood
glucose level. Individuals with diabetes are required to repeat this process at least 5 times daily
in order to closely monitor their metabolic levels. In spite of this, some individuals forgo this
process as it has been reported to be painful which puts them at risk of developing further
health problems linked to inadequate blood glucose level monitoring and management.
In order to improve people’s management of diabetes, it is imperative to have a non-invasive
system that allows for the constant monitoring of blood glucose levels. Modern technological
advancements have resulted in the development of devices which are minimally invasive. A
study gives an example of the GlucoWatch Biographer which made use of transdermal fluid to
determine the blood glucose level [6]. However the production of this product was discontin-
ued as it resulted in skin irritation amongst some users. Another study also reviews a similar
product - the European produced Pendra - which is a watch like blood glucose monitoring de-
vice [2]. This device utilized “impedence spectroscopy requiring no extraction of tissue fluid,”.
Moreover, the Pendra could provide minutely real time readings and hyperglycemia and hypo-
glycemia alerts. However, home use of the Pendra revealed that readings were imprecise which
resulted in it being pulled from the market for further enhancements.
3.7 Continuous assessment of blood pressure
Although it is usual overlooked, blood pressure (BP) is one of the most important vital signs
that require monitoring. A significant number of people who have hypertensions do not exhibit
any symptoms hence they have no need to seek medical attention which leads to them pay-
ing no heed to this ailment. The significance of BP has been highlighted by scholars such as
Kikuya et al [55] and Pringle et al [29] who both purport that BP can be linked to morbidity
and mortality due to its close association with cardiovascular illness. Over the years wearable
biomedical sensors for BP monitoring and assessment have been developed on the basis of tra-
ditional techniques like the oscillometric technique. Such devices usually measure BP through
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the brachial artery in the upper arm. Modifications have been made to BP measuring biomed-
ical devices to incorporate sensors in a watch like device which uses the radial artery in the
wrist for measurement. The first watch based BP monitoring system was developed by Casio
in 1992. However this venture was discontinued however since then modifications have con-
tinuously been made to perfect and improve this innovative device [100]. Devices which have
built on Casio’s BP watch system include the MediWatch which utilizes arterial tonometry to
record radial pulse waveforms and supply BP measurements [47]. Similarly, another study con-
ducted earlier research which looked at Vasotrac which is also a wearable wrist device for BP
monitoring [46]. Vasotrac also measures BP after 12 - 15 beats through waveforms acquired
from the radial artery. A study looked into the development of “a novel adaptive algorithm
for calibrating non-invasive pulse transit time (PTT) measurements to arterial blood pressure
(BP) [25].” This pioneering algorithm - which was incorporated into a wearable sensor - aimed
to allow for the comprehensive calibration of PTT to BP with no need for an oscillometric
blood pressure cuff.
3.8 Continuous assessment of individual health and well-being
The use of remote vital sign monitoring systems has become more and more important as the
shift towards ‘at home’ care - especially for elderly patients and for rehabilitation purposes -
has increased. In light of this, extensive research has been conducted to evaluate the efficacy
of wearable sensors in keeping track of the daily activities of elderly people, individuals who
suffer from chronic illnesses and people undergoing rehabilitation in the home environment. A
research conducted by Lovell et al. [54] showed that the use of accelerometers in determining
the level of performance of active daily living activities by elderly people being monitored in
their homes was effective and expedient. Various innovations have been developed in order
to assist with this monitoring system. A study looked into the monitoring of activities such
as sitting, walking and standing through developing a pressure and acceleration sensor system
which was in-built in shoes. This system was also able to concurrently sense if the individual
was also engaging in arm movements [30]. Similarly, another study devised a step counting
device based on an accelerometer for people with Parkinson’s disease [27].
Apart from monitoring activity, wearable sensors have also been implemented in patient recov-
ery tracking. A study illustrated how wearable sensors could be used to monitor the recovery
process of people who had undergone abdominal surgery [69]. Additionally, a number of re-
search projects focusing on the monitoring of patient activity have shown that such applications
can significantly increase an individual’s compliance to exercise.Two studies look at the use of
wearable devices in monitoring the physical activities of individuals who suffer from obesity
and concur that such devices are useful especially when used in clinical interventions which
aim to promote an active and healthy lifestyle amongst patients [7, 52]. In line with this,
there are a number of projects that are investigating the usefulness of incorporating wearable
devices in clinical assessments. A study gives an example of LiveNet which is a monitoring
system that measures electrocardiogram (ECG), electromyography and 3D acceleration [59].
This system developed at MIT system has been considered for use in observing the symptoms
of Parkinson’s disease and detecting epilepsy induced fits. Similarly, another study highlighted
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the effectiveness of LifeGuard which is a monitoring system designed to keep track of the
health status of people residing in areas with extreme conditions such as space [16]. Wearable
monitoring devices have also been developed to monitor the vital signs of high risk individuals
with illnesses such as cardio-respiratory diseases. With regards to this, another study speaks
of how the FP5 program under the European Commision led to the development of a device
worn on the wrist that can detect and record an individual’s blood pressure, temperature and
ECG [91]. In addition to this, a number of similar projects under the European Commission
that have also developed devices of a similar nature which include the MyHeart project which
was put in place to prevent and diagnose cardiovascular diseases through monitoring an indi-
vidual’s vital body signs [37].
3.9 Fuzzy Cognitive Mappings as a tools for medical decision
making
The application of Fuzzy Cognitive Mapping (FCM) techniques in the generation of various in-
telligent systems has been vastly successful in a number of applications. The intricate construc-
tion process and infrastructure of Fuzzy Cognitive Maps is reflective of the immense knowl-
edge and experience required in creating FCMs that accurately mimic the decision making and
logicizing process [85]. In the area of healthcare and medicine, such decisions tend to be
climacteric and need to be executed with promptness. In light of this, FCMs have been incor-
porated in the development of Decision Support Systems (FCM-DSS) which have been used
for differential diagnosis purposes [93]. A study states that FCMs are especially suitable for
healthcare related applications because of the complex nature of medical systems and their use
of imprecise, irresolute and equivocal data that is constantly changing [58].
3.10 Fuzzy Cognitive Mappings as a diagnostic tool
The underutilization and excessive use of diagnosis tests can have significant impacts on health
and cost of health care. Hence decision support technology aims to maximize diagnostic test
use in the healthcare sector through assisting healthcare practitioners with the establishment
of diagnosis [71]. The use of Clinical Decision Support Systems (CDSS) helps to enhance
the quality of patient safety and care. A number of studies assessing the implementation of
CDSSs in health care have found that they are highly effective particularly with regards to
patient diagnosis and therapy [26]. In light of this, Fuzzy Cognitive Maps (FCMs) have been
used as tools to model and control intricate systems with innumerate variables and factors in
medical decision support. As a result, FCMs have been utilized in the diagnosis of a variety of
illnesses.
Fuzzy Cognitive Mapping (FCM) has proved to be a useful tool in assisting healthcare practi-
tioners to make accurate patient diagnosis of various diseases. A study investigated the use of
a customized FCM model in the diagnosis of infant and child meningitis [95]. The FCM in this
case - which had a 95 percent accuracy rate - exhibited results with 83.3 percent sensitivity and
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80 percent specificity showing that FCM can provide practitioners with a dependable, front-end
decision-making tool. Research has also been conducted on the use of FCM in predicting the
severity of diabetes mellitus. Bhatia and Kumar developed a FCM system for decision support
to help healthcare practitioners evaluate a patient’s health status before diagnosis [11]. This
FCM system was specifically tailored for the diagnosis of diabetes mellitus using 50 cases.
With an accuracy of 96 percent, the system was able to efficiently predict a patient’s diabetes
severity. Positive results were also found by another study which looked into the integration
of FCM in the differential diagnosis of specific language impairment (SLI) from dyslexia and
autism [94]. Although the research was in it’s initial stage, there was promise of it being
successful in complimenting other diagnostic methods to aide speech pathologists in the dis-
cernment of of language and communication disorders. According to Mulik and Jadhav FCM
can be useful in the diagnosis and treatment of multiple kidney diseases [64]. Their FCM
system looked into the diagnosis and treatment of “nephrotic syndrome, renal tubular acidosis,
hyponatremia, kidney stone, urinary tract infection, kidney cancer, renal anemia, calculation of
kidney transplant allocation score and cytomegalovirus” [64]. Through the development of the
‘Fuzzy System for Diagnosis and Treatment of Kidney Disease (FSDTKD),’ which was used
to assist doctors and their assistants in decision making, a study found that such a FCM system
can be useful given that it provided an acceptable accuracy level [64]. However, the FSDTKD
called for further enhancement through having additional decision variables.
The prediction of pulmonary infections using FCM is an area that has also been researched. Pa-
pageorgiou and Froelich [72], pioneered the investigation of this area as a way to enhance the
predictive and diagnostic capabilities of medical practitioners. The FCM system utilized in this
research intended to revolutionize the FCM algorithms through a multi-step enhancement pro-
cess. The incorporation of this evolved FCM system exhibited promising results which point
towards the success and advantageous nature of using this in predicting pulmonary infections
such as pneumonia. However, the study expressed that further work is still needed to further
enhance the system [72]. Yet another pioneering study was undertaken by Beena and Ganguli
who looked at the development of a new algorithmic approach - which was based on a FCM
together with Hebbian learning [10]. The incorporation of Hebbian learning was to enhance
the FCM and the results it produced. The levels of damage detection from the system were 100
percent at a 50 percent noise level; whilst at a 70 percent noise level, damage detection was at
98.8 percent.
These tools provide useful outputs in form of monitoring displays, graphs representing a per-
son’s health over a period, priority lists and warnings generated when threshold values are
reached. These outputs are archived by performing functionality such as: time series analysis,
patient prioritization, computing the rate of deterioration and monitoring threshold values. The
outputs should help medical professional to make decisions.
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3.11 Continuous Glucose Monitoring Systems: Categories
and Features
There are a number of continuous glucose monitoring systems that were approved by the Food
and Drug Administration (FDA). The FreeStyle Libre Pro system (Abbott, Alameda, CA) is an
example. It consists of a sensor and a single reader device. The sensor is applied to the back of
a patient’s upper arm and requires a two minute activation period. Glucose levels are recorded
in 15 minutes intervals for up to 14 days [41].
Another successful professional Continuous Glucose Monitoring (CGM) is the Medtronic
iPro2 system (Medtronic, Northridge, CA). Is consists of the Enlite glucose sensor and the
iPro2 digital recorder. The Enlite glucose sensor is wearable for up to 6 days and glucose read-
ings are recorded every 5 minutes. At least one blood glucose entry be aqcuired in every 12 for
system uploading [41].
Several personal CGM systems are also available. The Abbott FreeStyle Libre flash CGM
system was FDA approved in September 2017 for stand-alone use. It consists of the FreeStyle
Libre sensor and the the FreeStyle Libre reader. The FreeStyle Libre sensor is wearable for up
to 10 days [41].
Another personal CGM is the Medtronic Enlite sensor which is used with and 630G insulin
pumps and Medtronic MiniMed 530G. Rate-of-change trend arrows and Real-time glucose
data are available every 5 minutes on the pump screen. Both pumps use Medtronic SmartGuard
technology. When glucose levels fall below a preset threshold insulin delivery is suspended for
up to 2 hours . The Enlite sensor is calibrated every 12 hours [41].
3.12 Conclusion
There are many technological solutions being implemented to improve healthcare. The fol-
lowing chapter discusses the low level software solutions that were proposed to solve the main
objectives of this study.
An in-depth understanding of the machine learning and graph algorithm implemented during
this study will be discussed in the following chapter 4.
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Patient Prioritization: Calculating the
Risk-score
The aim of a triage system is to determine a quantitative measure of patients’ medical condi-
tions and then give priorities to the most urgent cases. Some of the requirements to be met
by the algorithm behind such as system include: Interpretability, Speed, Simplicity, Scalability
and Accuracy. The algorithm should be scalable that is it should be portable enough to run on
small devices e.g. smart phones, tables, iPad, biomedical sensors and smart watches without
any problems. The solution must be efficient, accurate and easy to interpret. Figure 4.1 depicts
the patient condition recognition system proposed in this thesis. It has been implemented as a
data analytics platform that includes the following key components:
Figure 4.1: High-level overview of the situation recognition [1] [56].
Database: The database stores medical record history for the patients, time stamped patient
physiological parameter readings from the bio-medical sensors and also stores the triage results
for every patient record [56].
36
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Knowledge Based System: The scoring system uses domain knowledge to score the un-scored
patient history data from the database. The knowledge based system calculates the score using
weights provided by the experts (physicians) no learning is involved. The final triage scores
for every record are then fed directly into a machine learning model as training data [56].
Machine Learning Based System: A machine learning technique can be used to perform
intelligent data analysis in order to perform situation recognition and patient treatment priori-
tization [56].
Mobile Visualization: This application interfaces with the middleware to retrieve the patient
records and other data from the Database. The application presents the doctor with prioritized
patient records, real time heart rate monitoring, risk score time series monitoring and is also
able to visualize patterns discovered by a machine learning technique based system in the form
of graphical representations [56].
Middleware: The middleware interfaces with the database and the mobile visualization ap-
plication. The middleware interfaces with a) the database to acquire triage results obtained by
the scoring system and 2) the mobile visualization application to provide the prioritized patient
records and graphical representations [56].
4.1 Predictive Models
4.1.1 Gradient Descent Algorithm
Gradient descent can be defined as a “first-order iterative optimization algorithm for finding
the minimum of an objective function,” [32]. Gradient descent is also referred to as ‘steepest
descent.’ This algorithm is generally used in machine learning to find coefficients of ML algo-
rithms like logistic regression and neural networks. The gradient descent algorithm works by
using a model to make predictions on data and prediction error to create an updated model that
has a reduction in error. This algorithm aims to find model parameters which have minimized
model error through making changes along the gradient toward a minimum value in the model.
Hence the algorithms’ name ‘gradient descent.’ Based on the different ways of calculating data,
there are various types of gradient descent. The type of gradient descent to use will depend on:
1. Data volume
2. Time complexity
3. Algorithm accuracy
The three gradient descent variations are:
1. Batch Gradient Descent
2. Stochastic Gradient Descent
3. Mini-batch Gradient Descent
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4.1.2 Batch Gradient Descent
Batch gradient descent - which is also known as vanilla gradient descent – is a version of the
gradient descent algorithm which enumerates the gradient of a whole dataset. This works well
with fairly smooth error manifolds. Thereafter, an optimum solution can be attained, be it
local or global. Because batch gradient descent utilizes a complete dataset for a single update,
it tends to be somewhat slow. However, this version of gradient descent is computationally
efficient as it requires significantly less updates when compared to stochastic gradient descent.
Additionally, a more stable error gradient can be obtained with this algorithm because of the
infrequency of updates.
4.1.3 Stochastic Gradient Descent
According to Nicholas [68], stochastic gradient descent can be described as a simple, effectual
“approach to discriminative learning of linear classifiers under convex loss functions such as
(linear) Support Vector Machines and Logistic Regression.” It is another version of the gradient
descent algorithm which computes the error and updates the model one example at a time. This
gradient descent algorithm is often referred to as an ‘online machine learning algorithm.’ In
order to use stochastic gradient descent, the data set needs to be randomized first. Thereafter,
to update the parameters only one example in each iteration is used to calculate the gradient
of cost function. Hence this gradient descent algorithm tends to be faster than batch gradient
descent. However, accuracy may not be achieved using this approach. Stochastic gradient
descent is useful for error manifolds with numerous local maxima/minima.
4.1.4 Mini-batch Gradient Descent
The mini-batch algorithm is widely used as it generates precise results at a fast pace. This
approach makes use of a prescribed set of ‘m’ training data to calculate the gradient of the
cost function. Generally, mini-batch sizes are between 50–256 however this can fluctuate de-
pending on the application. As a result, the mini-batch gradient descent algorithm has reduced
discrepancies in the parameter updates and this leads to convergence stability. Additionally,
gradient computation can be done efficiently through the use of highly optimized matrix. Table
4.1 compares the three forms of gradient descent.
Algorithm Batch Mini Batch Stochastic
Accuracy High Moderate Low
Time Consuming More Moderate Less
Table 4.1: Comparing the types of gradient descents.
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4.2 Machine Learning Techniques
This chapter discusses the following models in detail MLiR, MLoR, CART, SNN and DNN.
Each algorithm performs 10 steps in order to prioritize patients. The steps are shown in Figures
4.2, 4.3, 4.4, 4.5 and 4.7.
The un-scored history data is scored and then fed into the machine learning model as training
data. If the history data is scored then steps 1 to 4 can be skipped and the scored history data
can be fed directly into the machine learning model. The most distinguishing characteristics of
the five machine learning algorithms discussed in this dissertation are step 5 and step 8.
4.3 Logistic Regression
Logistic regression is used for modelling event probabilities which can either be dichotomous
(binary) or multiple. The algorithm can either have one variable affecting the outcome (uni-
variate) or multiple dependent or independent variables affecting the outcome (multivariate).
There are three types of logistic regression that is ordinal, multinomial and binomial. The
binomial regression can have only one of the two possible outcomes. For example the possible
outcomes from playing a game of chess with someone at the same level as you is either a win
or a lose and can be represented by 1 and 0 respectively.
The multinomial logistic regression has many possible outcomes for example a sick patient
can either be diagnosed with disease A, disease B or disease C. The ordinal logistic regression
deals with dependent ordered variables.
The probability of an event can be measured in three ways that are regarded to be equivalent in
some way:
• Probability of the event, pi is a number between 0 and 1. The value one means it is certain
the event will occur and a zero value means it is certain the event will not occur. The
probability pi that Y = y is represented as
pi = P(Y = y) (4.1)
• Odds in favour of the event, ODDS(Y = y) is a number between 0 and ∞. The odds in
favour of Y = y is represented by the equation 4.2. The value zero means it is certain
the event will not occur, the value one corresponds to the probability one half and ∞
corresponds to certainty the event occurs.
ODDS (Y = y) =
P(Y = y)
1 − P(Y = y) =
pi
1 − pi (4.2)
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• Log-odds in favour of the event, log (ODDS (Y = y)) is a number between -∞ and ∞. A
value of -∞ means we are certain the event will not occur and -∞ means the event will
occur.
log ODDS (Y = y) = log
P(Y = y)
1 − P(Y = y) = log
pi
1 − pi (4.3)
The probability of an event was measured using the Log-odds in favour of the event which is
an number between -∞ and∞. The weights are calculated in step 5.
Figure 4.2 shows that the derived estimator in step 8 is defined as
logit(pi(x)) = β0 + β1x1 + β2x2 + ... + βpxp (4.4)
Where logit(pi(x)) is the log-odds in favour of the event, β0 to βp are weights, and x1 to xp are
input variables [1].
Figure 4.2: Classification using the Multivariate Logistic Regression algorithm [1].
http://etd.uwc.ac.za/
4.4. Linear Regression Gradient Descent 41
4.3.1 Logistic Regression Gradient Descent
Algorithm 1 GradientDescent(trainList[][], alpha,maxEpochs), Logistic Batch Gradient De-
scent
epoch = 0
hypothesis = []
weights = []
while epoch < maxEpochs do
epoch = epoch + 1
for integer index = 0 <trainList.Count do
double computed = ComputeS igmoid(trainList[index], theta)
hypothesis[index] = computed
integer targetIndex = trainList[index].Count − 1
double target = trainList[index][targetIndex]
weights[0]+ = alpha ∗ (target − computed) ∗ 1
for integer i = 1 <weights.Count do
weights[i]+ = alpha ∗ (target − computed) ∗ trainList[index][i − 1]
i = i + 1
end for
index = index + 1
end for
end while
return weights
Algorithm 2 ComputeS igmoid(dataItem[],weights), Batch Gradient Descent: Sigmoid
z = 0.0
z+ = weights[0]
integer i = 0
for i <weights.Count do
z+ = (weights[i + 1] ∗ dataItem[i])
i = i + 1
end for
return 1.0/(1.0 + Math.Exp(−z))
4.4 Linear Regression Gradient Descent
The Figure 4.3 shows that the derived estimator in step 8 is defined as follows:
yˆ = θ0 + θ1x1 + θ2x2 + ... + θpxp (4.5)
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Figure 4.3: Classification using the Multivariate Linear Regression algorithm [1] [57].
Where yˆ is the estimated y output value, θ0 to θp are weights, and x1 to xp are input variables.
The estimate yˆ is calculate in step 8 and the weights θ0 to θp are calculated in step 5 as shown
in Figure 4.3.
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Algorithm 3 GradientDescent(trainList[][], alpha,maxEpochs), Linear Batch Gradient De-
scent
integer epoch = 0
integer col = 0
integer row = 0
double columnTotal = 0
hypothesis = []
weights = []
while epoch < maxEpochs do
integer index = 0
for index < trainList.Count do
columnTotal = 0
col = 0
for col < numberO fColumns do
columnTotal = columnTotal + weights[col] ∗trainList[row][col]
hypothesis[row] = columnTotal
index = index + 1
end for
end for
col = 0
for col < numberO fColumns do
sumHminusY xX[col] = 0
col = col + 1
end for
row = 0
for row < numberO f Rows do
col = 0
for col < numberO fColumns do
sumHminusY xX[col] += (hypothesis[row] −trainList[row][numberO fColumns]) ∗
trainList[row][col]
end for
end for
col = 0
for col < numberO fColumns do
theta[col] = weights[col] −(alpha ∗ sumHminusY xX[col])/(double)(numberO f Rows)
end for
epoch = epoch + 1
end while
return weights
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4.5 Classification and Regression Decision Tree
Figure 4.4: Classification using the Classification and Regression Decision Tree algorithm.
Algorithm description: Unlike the other machine learning algorithms discussed in this disser-
tation. The CART algorithm derives the split node(s) in step 5. The split node(s) is(are) then
used to split the patient(s) data into classes in step 8 as shown in the Figure 4.4.
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Algorithm 4 GrowTree(D, F) : grow a feature tree from training data [33].
Input: data D; set of features F.
Output: feature tree T with labelled leaves.
if Homogeneous(D) then
return Label(D)
end if
S = BestS plit(D, F)
split D into subsets Di according to the literals in S
for each i do
if Di is not empty then
Ti = GrowTree(Di, F)
else
Ti is a leaf labelled with Label(D)
end if
end for
return a tree whose root is labelled with S and whose children are Ti
Algorithm 5 BestS plit(D, F): find the best split for a decision tree [33].
Input: data D; set of features F.
Output: feature f to split on.
Imin = 1
for each f in F do
split D into subsets D1, ...,Dl according to the values V j of f
if Impurity(D1, ...,Dl) <Imin then
Imin = Impurity(D1, ...,Dl)
f best = f
end if
end for
return f best
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4.6 Classification and Regression Decision Trees using Di-
rected Graphs
Step 1: Building the Decision Tree using a Directed Graph
Step 1.1: Expert Knowledge Input Format:
Parent Node, Child Node, Value 1 (e.g. Descriptive Text) , Value 2 (e.g. Quantitative Weight
such as Degrees of Freedom and Probabilities)
Step 1.2: Build the directed graph
Step 2: Classifying Attributes, Searching and Matching
Step 2.1: Attributes Input Format
Parameter 1 Value 1 (e.g. Descriptive Text) , Parameter 1 Value 2 (e.g. Quantitative Weight
such as Degrees of Freedom)
Parameter 2 Value 1 (e.g. Descriptive Text) , Parameter 2 Value 2 (e.g. Quantitative Weight
such as Degrees of Freedom)
Parameter 3 Value 1 (e.g. Descriptive Text) , Parameter 3 Value 2 (e.g. Quantitative Weight
such as Degrees of Freedom)
...
Parameter N Value 1 (e.g. Descriptive Text) , Parameter N Value 2 (e.g. Quantitative Weight
such as Degrees of Freedom)
Where N is the number of parameters available for classification
Step 2.2: Use Depth First Search / Breath First Search algorithm to Traverse the Graph
If the tree has costs (quantitative values) for each decision node And node not leaf then
use probabilities or degrees of freedom to compute a value that will be used for classification
else
match the attribute to the decision node and return the decision node
4.7 Deep Neural Network
The DNN calculates the weights which are used to predict the scores for the patient vital
parameters. The Figure 4.5 shows a software architecture for training and classification using
a DNN.
The DNN shown in Figure 4.6 is a 8-(10,10,10)-4 neural network. There are 8 input nodes, 10
by 3 hidden nodes and 4 output nodes. This might correspond to a problem where the goal is
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Figure 4.5: Classification using the Deep Neural Network algorithm [1].
to predict the priority level (Normal, Low, Medium and High) of a patient based on Systolic
Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Heart Rate and Peripheral Oxygen
Saturation (SPO2), where the input values are scaled using the gaussian normalizer. The SBP
= 231.8, DBP = 111.7, Heart Rate = 76.1 and SPO2 = 67 are scaled to 3.459, 5.075, 0.357 and
-3.166 respectively [1].
If Normal is encoded as (1,0,0,0) Low is encoded as (0,1,0,0) and Medium is encoded as
(0,0,1,0) and High is encoded as (0,0,0,1), then the DNN predicts a priority level of Low for
someone with SBP = 231.8, DBP = 111.7, Heart Rate = 76.1 and SPO2 = 67 because the last
output value 0.9453 is the largest.
Every connection between two nodes represents a weights and its bias. The weight is defined
as the strength or amplitude of a connection between two nodes from two successive layers.
4.8 Single Hidden Layer Neural Network
Similarly; the SNN in Figure 4.8 is a 8-(10)-4 neural network. There are a 8 input nodes,
10 hidden nodes and 4 output nodes. The goal is to predict the priority level (Normal, Low,
Medium and High) of a patient based on SBP = 231.8, DBP = 111.7, Heart Rate = 76.1 and
SPO2 = 67 [1].
If the parameters are encoded as in the DNN then the SNN predicts a priority level of Low
because the last output value of 0.999 is the largest and corresponds to Low as shown in Figure
4.8.
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Figure 4.6: Deep Neural Network 8-(10-10-10)-4 [1].
4.9 Multiple Layer Neural Network
The weights for both the DNN and the SNN are calculated in step 5 as shown in Figure 4.5 and
Figure 4.7. The outputs in a neural network are calculated using the equation; A.4 which can
be derived as shown in appendix A.
The machine learning algorithms implementation have been discussed at a very low level. The
following chapter will look at a cloud based solution at a high level.
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Figure 4.7: Classification using the Single Hidden Layer Neural Network algorithm [1].
Algorithm 6 GradientDescent(trainData,maxEpochs, learnRate,momentum) Back Propaga-
tion: High Level Pseudo Code
Input: trainData the matrix of features,
maxEpochs the number iterations it takes to adjust the weights,
learnRate, determines how fast the algorithm learns or how fast the weights change
momentum, a value between 0 and 1 that is increased to speed convergence by increasing
the size of steps taken towards the minimum by jumping from a local minima.
Output: weights
while some condition is met do
compute gradients of each output node
compute gradients of all hidden layer nodes
update weights and biases
return weights
end while
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Figure 4.8: Neural Network 8-(7)-4 [1].
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Disease Identification
5.1 Introduction
Two studies [4][5] use graph theory and social network analysis techniques to ease the bur-
den caused by chronic conditions on hospital by preventing unnecessary hospital admissions
and associated high costs. In this study graph theory is used to identify a patient’s illness by
matching the patient’s symptoms to the symptoms in the database or knowledge repository.
This study however uses machine learning techniques to calculate risk-scores. Patient prioriti-
zation is then used to give priority to high risk patients thereby preventing unnecessary hospital
admissions.
A study described a decision tree as a structure that represents procedure for classifying objects
based on their attributes. And each object is represented as a set of attribute/value pairs and a
classification [84].
Assuming a set of medical symptoms might be represented as follows:
Table 5.1: Classified patient medical symptoms [84].
Patient Cough Fever Weight Pain Classification
Mary no yes normal throat flu
Fred no yes normal abdomen appendicitis
Julie yes yes skinny none flu
Elvis yes no obese chest heart disease
The input (training data) and output (correct classifications) are provided therefore algorithms
such as the CART or the Decision Trees ID3 can be used to classify a new set of input data [84].
A decision tree such as the one illustrated in Figure 5.1 can be used to represent the Table 5.1.
The ID3 and CART algorithms are machine learning techniques. Machine learning techniques
are used when learning from experience is required before making a decision. However if
51
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a knowledge base of disease symptoms relations exists then this study also proposes consid-
ering use of data structures such as graphs and trees together with natural language process-
ing to implement a symptom checker. A related study also makes use of natural language
processing [97]. Algorithms such as depth first search (Appendix B) and breath first search
(Appendix C) can be used to traverse graphs.
5.1.1 Directed graph for decision making
The Figure 5.1 is a disease identification tree or graph. Each blue rectangle represents a con-
dition to be tested. The red oval represents a match (positive result) for a disease and the green
oval represents a no match (negative result) meaning no disease or illness. A single test case
can have many possible outcomes. The data structure can be constructed in such a way that it
can be used as a test for all the diseases and their symptoms. Each test case leads to another
path and terminates when a leaf node with the final outcome is reached. Tests are in the form
of a conversation and the algorithm is in control of the conversation. This algorithm is more
ideal in virtual nursing.
An example of a patient and virtual nurse conversation used to test the algorithm:
Question 1: Where is your pain [abdomen, throat, chest or none]?
Answer: none
Question 2: If previous answer is no pain. Are you coughing [yes or no]?
Answer: yes
Question 3: If previous answer is yes: Do you have a fever [yes or no]?
Answer: yes
Decision: you have flu
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Figure 5.1: Disease identification using a graph data algorithm [84].
A practical chest tree or graph used by medical practitioners is show in the following Figure 5.2.
Another example of a disease identification graph is the abdominal pain, chronic graph shown
in the following Figure 5.3.
http://etd.uwc.ac.za/
54 Chapter 5. Disease Identification
Figure 5.2: A more practical disease identification tree graph for a chest algorithm [24].
5.2 Human Symptoms-Disease Network (HSDN)
In [101], medical bibliography data is used to generate a human symptom disease network.
The connection between shared phenotypes (symptoms) and common genotypes (protein-
protein interactions) of two diseases are also illuminated. The study extracted data from the
extensive medical bibliographic literature records and the related Medical Subject Headings
(MeSH) metadata from PubMed [101]. There are seven different files that were created. The
following is a listing of the columns available in the first four files relevant to this study [101]:
1. MeSH Disease Term and PubMed occurrence
2. MeSH Symptom Term and PubMed occurrence
3. MeSH Symptom Term, MeSH Disease Term, PubMed occurrence and TFIDF score
4. MeSH Disease Term, MeSH Disease Term and symptom similarity score
The following networks were established from the data [101]:
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Figure 5.3: Abdominal Pain or Chronic Graph [20].
1. disease-symptoms relationships
2. disease-gene relationships
3. disease-disease networks based on symptom similarity
4. disease-disease networks based on genes (Protein-Protein Interactions)
5.2.1 Processing pipeline
This current study contributes by proposing an architecture that makes use of the networks
established by the study [101]. The acquisition of symptom and disease relationships was
covered by the authors of the study [101].
Medical Data knowledge base - This study uses disease-symptoms relationships data and
MeSH list of diseases. The diseases-symptoms data is used to construct the data analysis
system and the list of diseases is used to verify the suggested disease from the literature.
Data Network Analysis - The relationships between diseases, symptoms and genes are estab-
lished by building a HSDN. The HSDN can be queried and output is given for example symp-
toms can be provided as input and the degree centrality of each matching disease-symptoms
relationship is given as output.
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Data Visualization - This presentation of the output (diseases with at-least one matched searched
symptoms) from the data network analysis.
5.2.2 Why use data structures to perform disease identification
A medical data knowledge base containing disease-symptoms, disease-disease, and disease-
gene relationships was provided and data structures such as graphs and trees can easily repre-
sent these relationships. Machine learning algorithms such as CART or the Decision Trees ID3
can be used when the classification (i.e. the disease) related symptoms is not known.
5.2.3 Graph
A graph G is defined as an ordered pair G = (N, E) where N is a set of nodes or vertices or
points and the set E of edges connects the vertices N. Ei, j is an edge for the nodes Ni and N j,
where i and j is an index for vertex Ni and N j respectively [53].
5.2.4 Degree Centrality (DC)
The degree centrality DC of any node Ni in a graph is a network theoretic measure and is
defined as the number of edges n attached to the node Ni. Where i ∈ {0, 1, 2...i...n1} is the
node’s index [15].
The number of symptoms in disease Di exhibited by the patient is n. The DC of any disease Di
measures the number of symptoms n.The HSDN is a graph G and its output is a set L of DC,
such that DC ∈ L.
5.2.5 Building and Searching the Symptoms Disease Network
The types of HSDN networks were established; binary tree based, zero-Edge graph based and
n-Edge graph based. The three types of HSDN were named based on the state of the disease-
symptoms sub graphs S , S ∈ G. A tree is an undirected graph in which any two nodes are
connected by exactly one edge(path).
zero-Edge graph based HSDN
The disease-symptoms relationship is represented by a graph with no edges. The disease is
represented by the node on index zero of the graph node list and the other nodes represent the
symptoms. The order of the symptoms in the node list is not important. This is illustrated by
Figures 5.7 and 5.8.
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n-Edge graph based HSDN
The disease-symptoms relationship is represented by a graph with n edges and n symptom
nodes. The disease is represented by the node on index zero of the graph node list and the other
nodes represent the symptoms. The order of the symptoms in the node list is not important and
all symptoms nodes are connected to the disease node. The order of the symptoms is not
important. This is illustrated by Figures 5.9 and 5.10.
Algorithm 7 S earch(G, symptoms), Symptom Search Algorithm: Graph Based
Input: symptoms, the symptoms to be searched
Input: G, the human symptoms disease network (HSDN graph)
Output: degree centrality list L, DC ∈ L
for each node ∈ G do
Initialize degree centrality graph G, G ∈ L
for each symptom ∈ symptoms do
Initialize sub graph, S , S ∈ G
if symptom ∈ S then
if G node count is zero then
add node at index zero of S to G
end if
add symptom to L
end if
end for
if G has nodes then
add G to L
end if
end for
return L
Binary tree based HSDN
The disease-symptoms relationship is represented by a binary tree. The disease is represented
by the root node of the tree structure and the other nodes represent the symptoms. The order
of the symptoms is not important. This is illustrated by Figures 5.11 and 5.12.
The binary tree based network has better performance since the binary tree algorithm has a
better search time complexity than that of the graph algorithm as shown by Table 5.2.
Pattern Matching
The Boyer Moore pattern matching algorithm was used to match the symptom terms in the tree
and graph based networks.
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Algorithm Time Complexity
Search
Time Complexity
Insert
Responses
Binary Tree O(log n) where n
is the number of
nodes in a tree.
O(log n) Two
Graph O(log |E|+log |V |)
where E is the
number of Edges
in a graph and
V is the number
of vertices in a
graph.
O(1) Many
Table 5.2: Comparing the binary search tree and a graph.
Algorithm 8 S earch(G, symptoms), Symptom Search Algorithm: Tree Based
Input: symptoms, the symptoms to be searched
Input: G, the human symptoms disease network (HSDN graph)
Output: degree centrality list, L,DC ∈ L
for node ∈ G do
Initialize degree centrality graph, G, G ∈ L
for symptom ∈ symptoms do
Initialize sub tree, S , S ∈ G
if symptom ∈ S then
if G node count is zero then
add the S root node to G
end if
add symptom to G
end if
end for
if G has nodes then
add G to L
end if
end for
return L
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Figure 5.4: Construction of the HSDN [101].
Figure 5.5: Processing Pipeline.
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Figure 5.6: Example node Ni with a DC value of 4.
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Figure 5.7: Disease identification through symptom search (zero-Edge Graph).
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Figure 5.8: Disease-disease network based on symptom similarity (zero-Edge Graph).
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Figure 5.9: Disease identification through symptom search (n-Edge Graph).
http://etd.uwc.ac.za/
64 Chapter 5. Disease Identification
Figure 5.10: Disease-disease network based on symptom similarity (n Edge Graph).
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Figure 5.11: Disease identification through symptom search (Binary Tree).
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Figure 5.12: Disease-disease network based on symptom similarity (Binary Tree).
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Chapter 6
Software Analysis and Design
6.1 Introduction
In this section the problem and requirements are identified and the system is decomposed into
components.
6.1.1 Requirements
There are multiple Ehealth business capabilities that can be implemented to help automate
some manual processes in public hospitals and clinics. Ehealth solutions can be large and
complex and the proposed solution should enable continuous delivery and deployment. Two
business capabilities are proposed; patient prioritization and condition recognition. Some parts
of the application should be accessible through authentication and also depending on the user
roles. The application should be deploy-able on any cloud platform and should be able to run
locally on a mobile device when there is no connectivity. Should be able to connect and update
the database once there is internet connectivity.
67
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6.1.2 Monolithic Architecture
The figure 6.1 below shows the relationship between the hexagonal architecture and the clean
architecture.
Figure 6.1: Monolithic Hexagonal and Clean Architecture.
The hexagonal architecture is an example of another architecture design that is used to develop
monolithic application. As more functionality is developed a monolithic application becomes
big and monstrous which leads to undesirable characteristics such as) [77]:
• difficult to understand and modify
• unable to support continuous delivery and deployment
• not easy to scale
• does not support polygloting
6.1.3 Proposed Architecture
The microservice architecture was proposed since it enables continuous delivery and deploy-
ment.
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Microservice architecture is an a architectural style that is used to implement business capabili-
ties as loosely coupled services (microservices) [77]. The problem is decomposed into different
business capabilities and each one of them is represented by a service.
In software development containerization is an approach in which a service or an applica-
tion, its configuration and its dependencies are packaged together as a container image. The
containerized application can be deployed as a container image instance to the host operat-
ing system (OS) and the unit can also be tested as a unit. Containers are lightweight, easily
packed and designed to run anywhere. A microservice is an application has a single business
capability [18].
Figure 6.2 shows how three services i.e. identity, patient and condition were derived from their
business capabilities identity management, patient management and condition management
respectively.
Figure 6.2: Decomposition by business capabilities.
The solution follows a microservices architecture and each service has it own context. This
means each service will have its own database see Figure 6.4. The three main microservices
are as follows:
• Patient Service: This microservice is responsible for patient management and its main
purpose is to calculate the risk score and perform patient prioritization. It consists of
the following algorithms: deep neural networks, single hidden layer neural networks,
multiple variate linear regression, multiple variate logistic regression and classification
regression decision trees.
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• Identity Service: The identity microservice is responsible for user management or au-
thentication.
• Condition Service: This condition microservice is responsible for disease identification
or condition recognition.
Each microservice has its own context, database, unique port and can be deployed into its own
container.
Figure 6.3: Bounded Context.
Bounded context defines boundaries of a complex domain into business context. It allows
a ubiquitous language that is shared and valid within a boundary to be defined) [77]. The
domain expert of the condition management system may not understand anything about the
patient management system) [77]. The bounded context supports high cohesion. Figure 6.4
shows how the services in proposed solution are bounded to each other.
The microservice architecture is a collection of different architectural patterns. The event
driven architecture, command pattern and the asynchronous request response pattern are some
of the patterns used to implement the solution. See the illustration shown in Figure 6.4. Each
micro service is hosted in its container hence why the different ports illustrated in Figure 6.5.
The ip address is the same for all the containers showing that they are all hosted on the same
machine.
6.2 Modeling Tools
Figure 6.6 shows the tools used to prototype the algorithms and the programming language
used to develop the solution.
The prototyping of the proposed system was done using octave and then implemented using c
sharp. Scikit a python library was used from classification and regression.
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Figure 6.4: Microservices Architecture: Requests, Responses, Commands and Events.
The advantages of using programming languages like c and c-sharp is that they are supported
by most electronic devices. The program can be run on small portable wearable devices.
6.3 Development Tools, Languages, Libraries and Frame-
works
The following languages were used to build the client application:
• MsSQL and Mongo database: used to store historical patient data and other data like
diseases and symptoms
• Firebase database: is a local storage database used by the client application when there
is no internet or intranet connection.
• C sharp language: developing the client application back-end and micro-services. It is
type safe and this comes with its advantages. Its syntax is very well designed and code
is easily architected into readable code.
• Type Script language: used to integrated external libraries like D3 with frameworks like
Angular 2+. Type Script supports strongly typed programming, access modifiers which
allows encapsulation, supports generic programming. It makes it easy to follow SOLID
principles and Object Oriented Programming to build your front-end application.
• Angular 2+: used to build the front-end client application. Angular 2+ was chosen
because it makes use of typescript. Angular is a very rich front-end framework.
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Figure 6.5: Microservices Architecture IP:PORT.
• D3.js visualization library: used for graphical visualizations. D3 can be used to develop
advanced visualizations.
http://etd.uwc.ac.za/
6.4. Visualizations 73
Figure 6.6: Prototyping, Programming Languages and Tools.
6.4 Visualizations
Visualizations were implemented in Type Script using a Java Script library D3 a data visual-
ization library. There are five main visualizations that were designed and developed see the
following Figures 6.7, 6.8, 6.9 and 6.10. The visualizations presented in this chapter are the
main features for the proposed solution and more information is explained in Appendix D to
Appendix H.
The patient vital signs are used to classify each patient and priority list as one shown in Figure
6.8 is generated.
The gauge on the left illustrated in Figure 6.7 shows the patient’s priority score which can
either be 1, 2 or 3 representing normal, low, medium or high priority respectively. The priority
scoring system follows the South African Triage system and this can be useful in hospitals and
clinics.
The gauge on the right shows the patient’s overall health which can be any value between 0 and
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Figure 6.7: Priority and overall health visuals.
100 percent. The score is then compared to other individuals scores saved in the database. This
can be connected to a wearable device such as a watch that also measures a person’s heart rate.
This gauge basically measures an individual’s activities and basically the aim is to promote a
health living. An individual can also track their diet and a score is calculated.
Figure 6.8: Prioritization.
Figure 6.8 shows the patient’s priority list which is colour coded as red, orange, yellow, and
green representing a priority score of 3, 2, 1 and 0 respectively.
The risk score for each individual can be plotted on a line graph as shown on Figure 6.9.
http://etd.uwc.ac.za/
6.4. Visualizations 75
Figure 6.9: Risk score time series monitoring.
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Figure 6.10: Heart rate time series monitoring.
Figure 6.10 shows that the heart rate can also be tracked using line graph visualisation. The
plot does not show actual patient data. The illustration shows future implementations that can
be included in the solution.
The user stories are described in Appendix D, Appendix E, Appendix F, Appendix G and
Appendix H.
There are five roles medical practitioner, medical trainee, developer, administrator and patient.
The developer role has access to the advanced settings or DNN optimization settings shown in
(Figure F.1 and Figure F.2) The developer role and the administrator have access to the man-
age accounts screen (Figure G.1), the manage account screen (Figure G.2) and role assigning
(Figure G.3). Every role has access to the manage personal profile screen (Figure H.1). The
medical practitioner, medical trainee, and administrator role have access to the patient priority
list screen (Figure D.1). All the roles have access to the priority score and overall health gauges
(Figure E.1), heart rate monitor (Figure E.2) and risk score monitor (Figure E.3).
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Experimental Evaluation
This chapter presents the experimental evaluation for both proposed patient prioritisation and
disease identification systems.
7.1 Patient Prioritisation
7.1.1 Methods of Evaluation
The regression algorithms were evaluated using a data set containing 17255 records and train-
ing to test ratio of 40:60. At the beginning of the study hospitals were contacted in-order to
acquire data to train the algorithms. However the acquisition was unsuccessful therefore an
alternative source of data was used. The continuous vital sign data for thirty two individuals
undergoing surgical cases who underwent anaesthesia was acquired from The University of
Queensland [92]. The records were combined to make the 17255 records data set.
Mean Squared Error (MSE)
The MSE also known as Mean Squared deviation (MSD) of an estimator measures the average
of squares of deviations of the estimated from the estimator. An MSE value of zero means
there was no variance between the estimated and the estimator. Therefore values close to zero
indicate a very small difference between the estimator and the estimated.
MS E =
1
n
n∑
i=1
(Yˆi − Yi)2 (7.1)
Where Yˆ is a vector of estimated or predicted values and Y is a vector of the actual output
values that are used to train the algorithm.
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7.1.2 Coefficient of Correlation (R)
Is a measure of correlation and dependence, that is the statistical relationship between two or
more random or bi-variate variables. Also defined as the degree to which two or more variable
are associated with each other.
The values range from -1 to 1, the value -1 represents a strong negative goodness of fit, the
value 1 represents a strong positive goodness of fit and a value close to zero represent a weak
relationship.
Accuracy
The model is trained using 40 percent of the data and the other 60 percent of the data is used
for cross validation.
In this study machine learning techniques are used to score the data. The triage score is then
verified by the standardized South African triage system and its values assigned a status true
positive (TP), false positive (FP),true negative (TN) and false negative (FN). These statuses
are used to construct a confusion matrix whose values are used to calculate the Precision as
defined by equation 7.4. The accuracy is then computed from the precision as depicted in the
equation 7.6.
The recall and precision are calculated inorder to find the overall performance of the algorithm.
Patients records are classified in four classes high, medium,low and normal. A record classified
as normal means the patient is not sick and if classified as low, medium and high then the
patient is sick. For an easy of interpretation and computation of the overall performance of the
algorithm, the precision and recall can be taken as a binary classification. The class normal is
represented by the class “not-patient” and the classes (low, medium and high) are represented
by the class “patient”. This is possible since during testing every predicted value is always
compared to the original target value regardless of the class (normal, low, medium and high).
Therefore this assumption does not affect the overall performance results.
The accuracy is also calculated by comparing the estimator and the estimated and at the same
time counting the number of matches.
Accuracy(%) =
NoM
NoR
× 100 (7.2)
Where NoM is the number of matches and NoR is the number of records in the test sets.
Epochs
The number of iterations the gradient descent algorithm takes to adjust weights and biases
in-order to attain the highest accuracy.
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7.1.3 Predictive Models
The Multivariate Logistic Regression (MLoR), Multivariate Linear Regression (MLiR), Single
Hidden Layer Neural Network (SNN), Classification and Regression Decision Tree (CART)
and Deep Neural Network (DNN) algorithms are evaluated and compared to determine the
best algorithm to perform multiple classification.
Artificial Neural Network: Optimization
The Table 7.1 shows an attempt to increase the accuracy of the SNN algorithm by increasing
epochs. Increasing the epochs had no effect on the accuracy of the algorithm. Also the best
optimum α and momentum have a positive effect on time it takes to train the algorithm.
Algorithm α MSE Accuracy (%) Epochs Time (min)
SNN 8-(7)-4 0.3 0.12 93.60 1000 0.80
SNN 8-(10)-4 0.3 0.05 97.88 1000 0.08
SNN 8-(10)-4 0.3 0.05 97.88 10000 0.12
SNN 8-(10)-4 0.3 0.05 97.88 100000 0.11
Table 7.1: Optimizing the Single Hidden Layer Neural Network.
In Table 7.2 the best Learning Rate (α) value was found to be 0.02 and increasing epochs also
improved the accuracy.
Algorithm α MSE Accuracy (%) Epochs Time (min)
DNN 8-(10-10-10)-4 0.01 0.026 94.97 1000 0.74
DNN 8-(9-11-9)-4 0.01 0.0010 97.86 1000 7.17
DNN 8-(9-11-9)-4 0.02 0.0040 99.16 1000 0.74
DNN 8-(9-11-9)-4 0.02 0.0033 99.16 2500 1.92
DNN 8-(9-11-9)-4 0.02 0.0013 99.68 5000 3.75
DNN 8-(9-11-9)-4 0.02 0.0008 99.68 7500 5.56
DNN 8-(9-11-9)-4 0.02 0.0007 99.86 10000 7.42
DNN 8-(9-11-9)-4 0.02 0.0007 99.86 12500 11.38
DNN 8-(9-11-9)-4 0.02 0.0007 99.86 15000 11.49
DNN 8-(9-11-9)-4 0.02 0.0007 99.83 17500 13.88
DNN 8-(9-11-9)-4 0.02 0.0006 99.88 20000 15.20
DNN 8-(9-11-9)-4 0.02 0.0006 99.88 22500 20.11
DNN 8-(9-11-9)-4 0.02 0.0006 99.88 25000 19.42
Table 7.2: Optimizing the Deep Neural Network.
The Figure 7.1 shows that the time it takes to train the DNN increases as the number of epochs
increases. In Figure 7.2 the DNN’s accuracy also increases as the number of epochs and time
to train increases.
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Figure 7.1: Epochs over Training Time.
Figure 7.2: Accuracy over Epochs.
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Confusion Matrix
Table 7.4 shows data for patients who have been given anesthesia. If the data is scored using a
triage system and the triage score is verified by the doctor and assigned a status false positive
(FP), true positive (TP), false negative (FN) and true negative (TN). The confusion matrix
shown in Table 7.3 is calculated using equations 7.3, 7.4 and 7.5.
Recall or Detection or Hit rate or True Positive Rate
Recall =
T P
T P + FN
(7.3)
Precision =
T P
T P + FP
(7.4)
Falserate =
FP
T N + FP
(7.5)
actual
value
Prediction outcome
p n total
p′ True
Positive
False
Negative P
′
n′ False
Positive
True
Negative N
′
total P N
Table 7.3: Confusion Matrix.
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Table 7.4: An example patient data set.
Actual
Normal Patient Total
Predicted
Normal T N = 1 FN = 3 4
Patient FP = 2 T P = 9 11
Total 3 12 1
Table 7.5: Confusion matrix for the example data set.
The confusion matrix for the data shown in Table 7.4 can be represented by Table 7.5.
The confusion matrix precision parameter can be used to calculate the accuracy as shown in
equation 7.6. The accuracy calculated using equations 7.2 and 7.6 are equivalent.
Accuracy = Precision × 100 (7.6)
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7.1.4 Best Performance
The MLoR, MLiR and SNN algorithms were trained using a learning rate alpha value of 0.3 in
1000 iterations or epochs in order to achieve their best performance. The DNN algorithm was
trained using a learning rate value of 0.02 in 10000 epochs. The DNN’s accuracy increases as
the number of epochs increases see Figure F.2 however this has a negative effect on the time it
takes to train the algorithm.
The DNN has the best accuracy however it has the worst running/execution time. The MLiR
has the best running/execution time but not the best accuracy. Both accuracy and time com-
plexity of the algorithms are important. Both algorithms calculate weights which are used
to calculate the output /estimate when given input parameters. These weights can be cached,
saved in a file or database hence no need to recalculate the weights every time when calculating
the output/estimate of new input values. The weights are only recalculated when given a new
set of training data therefore the running/execution time is not as important as the accuracy.
Figure F.1 in the Appendix D shows a visualization that can be used to optimize the algorithm.
Three parameters i.e. learning rate, momentum and max epochs can be adjusted until the best
performance is achieved.
Algorithm α MSE Accuracy (%) Classification Time (s)
MLoR 0.3 0.06 85.00 Multiple 0.22
MLiR 0.3 0.05 90.60 Multiple 0.12
CART N.A 0.00 100.00 Binary 14.07
SNN 0.3 0.05 97.88 Multiple 4.81
DNN 0.02 0.001 99.86 Multiple 430.03
Table 7.6: Machine Learning Algorithms Performance Comparison.
7.2 Disease Identification
7.2.1 Method of Evaluation
The HSDN analysis algorithms is evaluated using a data set containing 147978 symptoms-
disease records. The data structures are known to consume a lot of resources (memory and
cpu). Performance testing is carried out by measuring the execution time and CPU usage of the
algorithm as the data increases. When two or more programs are running simultaneously they
tend to compete over resources. A constant environment is established by making sure only
the HSDN program is running whilst monitoring the CPU usage and memory consumption.
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7.2.2 Building and Searching the HSDN
Four symptoms (Fever, Pain, Vomiting and Diarrhea) are searched during the evaluation of the
three networks (n-Edge graph based, zero-Edge graph based and the binary tree based). About
2548 diseases with at-least one of the four mentioned symptoms are found. The illustrations
Figure 7.3 and Figure 7.4 show that the execution time of the three networks increases as the
amount of data increases.
The binary tree based network performs better than the other two networks.
Figure 7.3: Execution time over amount of data (Searching the HSDN).
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Figure 7.4: Execution time over amount of data (Building the HSDN) .
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Conclusion and Future Work
8.1 Conclusion
Medical knowledge can be accessed electronically in a more effective way using directed
graphs which can easily show the relationships between diseases and their symptoms. Medical
conditions can share symptoms and a condition can lead to another. Most pseudo science meth-
ods fail to eliminate human errors and other systematic errors. In machine learning scientific
methods have ways to reduce biases during training. The abnormal values tend to move away
from the model’s best line of fit and hence can be ignored Open source technology was chosen
and hence there are no subscription fees paid to make use of libraries, frameworks or services.
This study supports the use of vital parameters to measure patient risk scores. Pre-diagnosis
and virtual nursing was successfully achieved through disease identification from symptoms
using a key value binary tree and a directed graph. A heart attack pre-diagnosis graph was
provided as an example of a early warning or pre-diagnosis test. The same graph data structure
can be used to implement pre-diagnosis tests for other diseases such as diabetes. The graph
data structure can be used to represent disease-symptoms and disease-disease relationships and
there by automating medical knowledge. Visualizations were designed to help medical experts
interpret the results from ML algorithms.
The MLoR, MLiR, SNN and DNN were found to be useful in multiple classification. The
CART algorithm produced excellent binary classification results.
Some ML algorithms can achieve a very high accuracy close to 100%. As the problem becomes
complex ML algorithms such as DNNs can be used. The DNN can take many variables and
still achieve high accuracy by learning over time through the increase of epochs. DNN can
also process qualitative data by encoding the values to numeric values. The use of automated
systems eliminates human error altogether. The algorithms are trained using a small sample
and can accurately classify any other set of parameters. In this study forty percent of the data
was used to train the algorithm and the other sixty percent was used to test the accuracy of the
ML algorithms. This proves that scientific methods are more useful than pseudo-science health
systems.
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This study has proved to be a very good start to build an ehealth solution that is cost effective,
reliable and the results can be accessed in real time.
The disease-symptoms relationships analysis network was successfully implemented using
graphs and binary trees. The binary tree based HSDN was found to be the best performing
network.
The relationship between the main objectives of this study i.e. patient prioritization and disease
identification was not shown. Patient prioritization should be also be dependent on disease
identification and not only vital parameters. This relationship depends most on real patient data
and availability of medical professionals to validate correctness of the proposed architectures.
8.2 Future Work
The CART algorithm has an excellent performance and can be further configured to support
multiple classification. Multiple classification using CART will most likely produce better
results than the other two algorithms MLoR and MLiR.
Future work will include implementing applications of other disease identification networks
that is (1) disease-gene relationships and (2) disease-disease networks based on genes (Protein-
Protein Interactions). Processing of grammatical search phrases using machine learning will
be implemented in future.
8.3 Limitations
Access to medical data in South African hospitals still remains a problem. An attempt was
made to get real patient data from hospitals however the attempts were not fruitful. This study
is a motivates the importance of real data in research. There are rules and regulations that are
created to govern the use of medical technology within the health-care industry. There are
Privacy and Security Acts that play an important role in making sure that there is security and
safety with regards to patient information [21]. However that data can be anonymous and made
available for research.
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Appendix A
Neural Network Equations
Let n denote the number of layers in a neural network and m the number of nodes in a layer.
The layer l is labeled as Ll while the input layer is labelled L1 and the output layer as Ln,
l ∈ [1 . . . n]. Let θli j denote the weight associated with the connection between node i in layer
l, and node j in layer l + 1 with nodes i, j ∈ [1 . . .m]. Each layer can have a different number
of nodes M. Therefore each layer Ll ∈ [L1 . . . Ln] has ml ∈ [m1, . . .mn] number of nodes. The
activation or output value is denoted by a(l)i , where the i − th input i is the node number in the
layer l and βi is the bias of the weight. Consider that x1 to xm are input variables fed into the
neural network and m is the number of input variables. For l = 1, a(1)i = xi can be used to
denote the i − th input.
The first layer’s output for the neural network is a total weighted sum of inputs xi to node i in
layer l computed as follows:
hθ,β(x) = an1 = σ(θ
(n−1)
11 x1 + θ
(n−1)
12 x2 + ... + θ
(n−1)
1m xm + β
(n−1)
1 ) (A.1)
The sum
∑m
j=1 θi, ja
l
j can be written in short form as θ
lal where σ is the sigmoid function repre-
sented by equation A.2.
σ(z) =
1
1 + e−z
(A.2)
Therefore, a general expression of the estimator at a layer is an output value hθ,β(x) from the
previous layer which is expressed by the equation A.3
hθ,β(x) = a(l+1) = σ(θlal + βl) (A.3)
Where the θl ∈ [θ1 . . . θm] are weights, and x is the vector [x1 . . . xm] of the input variables
which are fed to the neural network and al ∈ [a1 . . . am] are input to a given node i in layer l
while βl is the bias at that layer. The equation A.3 can be explicitly defined by equation A.4.
a(l+1)i = σ(
m∑
j=1
θi, jalj + β
l) (A.4)
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Appendix B
Depth First Search
public IEnumerator<GraphNode<T>> DepthFirstSearch(Graph<T> graph, T start)
{
HashSet<GraphNode<T>> visited = new HashSet<GraphNode<T>>();
Stack<GraphNode<T>> stack = new Stack<GraphNode<T>>();
GraphNode<T> startNode = (GraphNode<T>)graph.Find(start);
stack.Push(startNode);
while (stack.Count > 0)
{
GraphNode<T> current = stack.Pop();
visited.Add(current);
yield return current;
foreach (GraphNode<T> neighbour in current.Neighbors.Reverse())
stack.Push(neighbour);
}
}
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Appendix C
Breath First Search
public IEnumerator<GraphNode<T>>
BreathFirstSearch (Graph<T> graph, T start)
{
Queue<GraphNode<T>> queue = new Queue<GraphNode<T>>();
GraphNode<T> startNode = graph.Find(start);
queue.Enqueue(startNode);
while (queue.Count > 0)
{
GraphNode<T> current = queue.Dequeue();
yield return current;
foreach (GraphNode<T> neighbour in current.Neighbors)
queue.Enqueue(neighbour);
}
}
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Appendix D
Priority List
Figure D.1: Patient Priority List.
To view the diagnosis results of a patient, select a record and click the button diagnosis. This
will open a dashboard with five visualizations mainly: the priority score gauge, overall health
gauge, heart rate monitor and risk score monitor see Appendix E.
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Appendix E
Dashboard
Figure E.1: Priority score and Overall health gauges.
The two gauges in Figure E.1 represent John Doe’s overall’s score from the patient priority list.
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Figure E.2: Heart rate monitor.
The Figure E.2 represents John Doe’s heart rate monitor. Real time monitoring is achieved
using SingalR, angular 4 and D3 visualizations.
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102 Chapter E. Dashboard
Figure E.3: Risk score monitor.
The Figure E.3 is a visualization showing John Doe’s hourly risk score.
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Appendix F
Advanced Settings and Visualizations
The Figure F.1 and Figure F.2 show the DNN optimization settings and visualizations.
Figure F.1: DNN optimization settings.
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104 Chapter F. Advanced Settings and Visualizations
Figure F.2: DNN optimization settings.
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Appendix G
Manage System Users
The Figure G.1, Figure G.2 and Figure G.3 illustrate role management. There are five possible
roles: medical practitioner, medical trainee, developer, administrator and patient. Access to
different sections of the system depend on the role assigned to the system user.
Figure G.1: View all users.
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106 Chapter G. Manage System Users
Figure G.2: Choose appropriate role and assign.
Figure G.3: Role assigned.
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Appendix H
Personal Profile
The manage account page allows each system user to edit his or her own details.
Figure H.1: Manage personal profile.
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